doc_id	sent_index	relation_id	relation	trigger	trigger_offset	arg_num	arg_base_np	arg_protein	arg_domain	arg_site	arg_sugar	PSource	SiteSource	NProtein	NID	SiteName	sent_text
33539901	10	47	gly	sialylated	2240:2249	arg1	sialylated antennae				sialylated antennae						These findings strongly suggest that hCTP enhances the in vivo biological activity of recombinant Japanese eel Gths due to the high abundance of O-linked glycans with sialylated antennae.
33295623	4	12	gly	α-dystroglycan	602:615	arg1	an unmodified peptide Ac- PPTTTTKKP-NH2 sequence			an unmodified peptide Ac- PPTTTTKKP-NH2 sequence	an unmodified peptide Ac- PPTTTTKKP-NH2 sequence		Site			sequence	Comparing the results for an unmodified peptide Ac- PPTTTTKKP-NH2 sequence from α-dystroglycan, and glycoconjugates with either modification on the Ts, we find that the impact of the α-O-Man modification on the peptide scaffold is quite limited, while that of the α-O-GalNAc is more profound.
33363672	10	100	gly	glycopeptides	1704:1716	arg2	several IgA glycopeptides			several IgA glycopeptides						glycopeptides	Partial cysteine oxidation was identified as an unexpectedly abundant peptide modification and impaired the automated processing of several IgA glycopeptides.
33149259	8	38	gly	glycoforms	1401:1410	arg1	these main PSA glycoforms	these main PSA glycoforms				PUBTATOR		PSA	354		The identification of these main PSA glycoforms altered in aggressive PCa opens the way to design specific strategies to target them, which will be useful to improve PCa risk stratification.
33068039	0	77	gly	glycoprotein	51:62	arg1	Machupo virus glycoprotein	Machupo virus glycoprotein				Fterm		glycoprotein			Tuning the binding interface between Machupo virus glycoprotein and human transferrin receptor.
32310329	0	56	gly	O-glycosylation	21:35	arg1	human coagulation factor V. BACKGROUND/OBJECTIVE Coagulation factor V	human coagulation factor V. BACKGROUND/OBJECTIVE Coagulation factor V				PUBTATOR		Coagulation factor V 	2153		Comprehensive N- and O-glycosylation mapping of human coagulation factor V. BACKGROUND/OBJECTIVE Coagulation factor V (FV), a multidomain glycoprotein, is an essential cofactor in the blood clotting cascade.
32310329	0	56	gly	O-glycosylation	21:35	arg1	FV	FV				Cterm		FV	2153		Comprehensive N- and O-glycosylation mapping of human coagulation factor V. BACKGROUND/OBJECTIVE Coagulation factor V (FV), a multidomain glycoprotein, is an essential cofactor in the blood clotting cascade.
32310329	0	67	gly	glycoprotein	138:149	arg1	a multidomain glycoprotein	a multidomain glycoprotein				Fterm		glycoprotein			Comprehensive N- and O-glycosylation mapping of human coagulation factor V. BACKGROUND/OBJECTIVE Coagulation factor V (FV), a multidomain glycoprotein, is an essential cofactor in the blood clotting cascade.
33301522	1	1	gly	N-glycopeptide	181:194	arg2	Native intact N-glycopeptide analysis			Native intact N-glycopeptide analysis						N-glycopeptide	Native intact N-glycopeptide analysis can provide access to the comprehensive characteristics of N-glycan occupancy, including N-glycosites, N-glycan compositions, and N-glycoproteins for complex samples.
33301522	1	24	gly	N-glycoproteins	335:349	arg1	N-glycoproteins	N-glycoproteins				Fterm		N-glycoproteins			Native intact N-glycopeptide analysis can provide access to the comprehensive characteristics of N-glycan occupancy, including N-glycosites, N-glycan compositions, and N-glycoproteins for complex samples.
33301522	1	39	gly	N-glycosites	294:305	arg2	N-glycosites			N-glycosites						N-glycosites	Native intact N-glycopeptide analysis can provide access to the comprehensive characteristics of N-glycan occupancy, including N-glycosites, N-glycan compositions, and N-glycoproteins for complex samples.
31967953	8	49	gly	A4α	837:839	arg1	l-Lys-Gly-l-Glu			l-Lys-Gly-l-Glu						Glu	The peptidoglycan type of RB2T was A4α, l-Lys-Gly-l-Glu.
35141446	3	48	gly	glycosylation	733:745	arg2	the O-linked glycosylation sites			the O-linked glycosylation sites						sites	To identify the specific biological functions of glycosylated sites in eCG, we constructed the following site mutants of N- and O-linked glycosylation: eCGβ/αΔ56, substitution of α-subunit56 N-linked glycosylation site; eCGβ-D/α, deletion of the O-linked glycosylation sites at the β-subunit, and eCGβ-D/αΔ56, double mutant.
35141446	3	72	gly	glycosylated	527:538	arg1	glycosylated sites			glycosylated sites						sites	To identify the specific biological functions of glycosylated sites in eCG, we constructed the following site mutants of N- and O-linked glycosylation: eCGβ/αΔ56, substitution of α-subunit56 N-linked glycosylation site; eCGβ-D/α, deletion of the O-linked glycosylation sites at the β-subunit, and eCGβ-D/αΔ56, double mutant.
35141446	3	99	gly	glycosylation	678:690	arg2	α-subunit56 N-linked glycosylation site			α-subunit56 N-linked glycosylation site						site	To identify the specific biological functions of glycosylated sites in eCG, we constructed the following site mutants of N- and O-linked glycosylation: eCGβ/αΔ56, substitution of α-subunit56 N-linked glycosylation site; eCGβ-D/α, deletion of the O-linked glycosylation sites at the β-subunit, and eCGβ-D/αΔ56, double mutant.
34118572	4	38	gly	composition	1202:1212	arg1	monosaccharide composition			position	monosaccharide composition					position	It was found that the molecular weight range and monosaccharide composition of polysaccharides, as well as the composition of small molecules, were identical between MHD and cSHD.
34123172	5	11	gly	glycosylation	984:996	arg2	glycosylation sites			glycosylation sites						sites	In addition, the large set of binding data collected allows us to examine the relationship between binding affinity and the correlation in motion between pairs of glycosylation sites.
33068039	3	61	gly	glycoprotein	610:621	arg1	glycoprotein sequence homology	glycoprotein sequence homology				Fterm		glycoprotein			Study of the experimental structure of Machupo virus glycoprotein 1 (MGP1) in complex with TfR and glycoprotein sequence homology has identified some residues at the interface that influence binding.
33068039	3	65	gly	glycoprotein	564:575	arg1	Machupo virus glycoprotein 1	Machupo virus glycoprotein 1				Fterm		glycoprotein 1			Study of the experimental structure of Machupo virus glycoprotein 1 (MGP1) in complex with TfR and glycoprotein sequence homology has identified some residues at the interface that influence binding.
33068039	3	65	gly	glycoprotein	564:575	arg1	MGP1	MGP1				Cterm		MGP1			Study of the experimental structure of Machupo virus glycoprotein 1 (MGP1) in complex with TfR and glycoprotein sequence homology has identified some residues at the interface that influence binding.
33231591	0	135	gly	composition	116:126	arg1	a high-fat fructose-rich diet			position	a high-fat fructose-rich diet					position	Effects of dietary fibre and protein content on intestinal fibre degradation, short-chain fatty acid and microbiota composition in a high-fat fructose-rich diet induced obese Göttingen Minipig model.
34298952	5	44	gly	glycoproteins	1055:1067	arg1	glycoproteins	glycoproteins				Fterm		glycoproteins			In the current work, we applied two plant lectins capable of distinguishing glycoepitopes with terminal GalNAc and Gal to identify glycoproteins that are their efficient carriers.
32672838	1	47	gly	glycosylated	310:321	arg1	the heavily glycosylated α-1-acid glycoprotein	the heavily glycosylated α-1-acid glycoprotein				Cterm		α-1-acid			The reactivity of a range of Keggin and Wells-Dawson type heteropolyacids (HPAs): H3 PW12 O40 H4 SiW12 O40 , H3 PMo12 O40 , K6 P2 W18 O62 , and NaH2 W12 O4 , towards the heavily glycosylated α-1-acid glycoprotein (AGP) is reported.
32672838	1	49	gly	glycoprotein	332:343	arg1	the heavily glycosylated α-1-acid glycoprotein	the heavily glycosylated α-1-acid glycoprotein				Cterm		α-1-acid			The reactivity of a range of Keggin and Wells-Dawson type heteropolyacids (HPAs): H3 PW12 O40 H4 SiW12 O40 , H3 PMo12 O40 , K6 P2 W18 O62 , and NaH2 W12 O4 , towards the heavily glycosylated α-1-acid glycoprotein (AGP) is reported.
35116628	5	58	gly	NRG1	823:826	arg1	the protein fucosylation level	NRG1			the protein fucosylation level	PUBTATOR		NRG1	3084		Then Aleuria aurantia lectin (AAL) ELISA was performed according to ELISA index to test the protein fucosylation level of NRG1 (Fuc-NRG1).
34516313	0	73	gly	polysialylated	82:95	arg1	novel polysialylated structures				novel polysialylated structures						High-resolution mass spectrometry reveals a complex ganglioside pattern and novel polysialylated structures associated with the human motor cortex.
33103831	6	61	gly	glycosylated	1220:1231	arg1	the O-linked and N-linked glycosylated proteins	the O-linked and N-linked glycosylated proteins				Fterm		proteins			The CEST contribution can be attributed to several phosphorylated products of GlcN, including uridine diphosphate-N-acetylglucosamine (UDP-GlcNAc), which is a substrate for the O-linked and N-linked glycosylated proteins that may be associated with the increase of the NOE signal.
32310329	5	11	gly	glycopeptides	841:853	arg2	glycopeptides			glycopeptides						glycopeptides	METHODS In this study, we comprehensively mapped the glycosylation patterns of human plasma-derived FV by combining multienzyme digestion, hydrophilic interaction chromatography enrichment of glycopeptides, and alternated fragmentation mass spectrometry analysis.
32310329	5	18	gly	glycosylation	702:714	arg1	human plasma-derived FV	human plasma-derived FV				Cterm		FV	2153		METHODS In this study, we comprehensively mapped the glycosylation patterns of human plasma-derived FV by combining multienzyme digestion, hydrophilic interaction chromatography enrichment of glycopeptides, and alternated fragmentation mass spectrometry analysis.
32862508	6	22	gly	fucosylated	1069:1079	arg1	unique fucosylated LacdiNAc-extended N-linked and O-linked glycans				unique fucosylated LacdiNAc-extended N-linked and O-linked glycans						Furthermore, mass spectroscopy revealed the existence of unique fucosylated LacdiNAc-extended N-linked and O-linked glycans in the gill tissues, whereas beta-elimination experiments showed that MrNV-VLPs demonstrated a binding preference for N-glycans.
33149259	7	15	gly	sialylated	1067:1076	arg1	blood serum PSA sialylated glycoforms				blood serum PSA sialylated glycoforms						The results showed that blood serum PSA sialylated glycoforms containing GalNAc residues were largely increased in aggressive PCa patients, whereas the disialylated core fucosylated biantennary structures with α2,6-SA, which are the major PSA glycoforms in standard PSA from healthy individuals, were markedly reduced in aggressive PCa.
33149259	7	52	gly	glycoforms	1078:1087	arg1	blood serum PSA				blood serum PSA						The results showed that blood serum PSA sialylated glycoforms containing GalNAc residues were largely increased in aggressive PCa patients, whereas the disialylated core fucosylated biantennary structures with α2,6-SA, which are the major PSA glycoforms in standard PSA from healthy individuals, were markedly reduced in aggressive PCa.
33149259	7	79	gly	glycoforms	1270:1279	arg1	the major PSA glycoforms	the major PSA glycoforms				PUBTATOR		PSA	354		The results showed that blood serum PSA sialylated glycoforms containing GalNAc residues were largely increased in aggressive PCa patients, whereas the disialylated core fucosylated biantennary structures with α2,6-SA, which are the major PSA glycoforms in standard PSA from healthy individuals, were markedly reduced in aggressive PCa.
33149259	7	89	gly	fucosylated	1197:1207	arg1	the disialylated core fucosylated biantennary structures				the disialylated core fucosylated biantennary structures						The results showed that blood serum PSA sialylated glycoforms containing GalNAc residues were largely increased in aggressive PCa patients, whereas the disialylated core fucosylated biantennary structures with α2,6-SA, which are the major PSA glycoforms in standard PSA from healthy individuals, were markedly reduced in aggressive PCa.
33149259	7	90	gly	disialylated	1179:1190	arg1	the disialylated core fucosylated biantennary structures				the disialylated core fucosylated biantennary structures						The results showed that blood serum PSA sialylated glycoforms containing GalNAc residues were largely increased in aggressive PCa patients, whereas the disialylated core fucosylated biantennary structures with α2,6-SA, which are the major PSA glycoforms in standard PSA from healthy individuals, were markedly reduced in aggressive PCa.
32885950	4	11	gly	used	817:820	arg2	ketone-d-Met			ketone-d-Met						Met	Newly synthesized azide-d-Leu and ketone-d-Met were used together with alkynyl-d-Ala for their metabolic assembly and then bioorthogonally encoded by the correspondingly fabricated DBCO-DOTA-Gd, HNO-DOTA-Eu, and azide-DOTA-Sm tags.
32885950	4	11	gly	used	817:820	arg2	Newly synthesized azide-d-Leu			Newly synthesized azide-d-Leu						Leu	Newly synthesized azide-d-Leu and ketone-d-Met were used together with alkynyl-d-Ala for their metabolic assembly and then bioorthogonally encoded by the correspondingly fabricated DBCO-DOTA-Gd, HNO-DOTA-Eu, and azide-DOTA-Sm tags.
32442573	8	10	gly	used	1251:1254	arg2	MGCH nanocomposite			MGCH nanocomposite						nanocomposite	This work proves that MGCH nanocomposite can be used as high-performance adsorbent for removing of phenolic pollutants from contaminated wastewater.
35141446	8	96	gly	glycosylation	1452:1464	arg2	O-linked glycosylation sites			O-linked glycosylation sites						sites	Our results indicate that the biological activity of eCG is greatly affected by the removal of N- and O-linked glycosylation sites in cells expressing eLH/CGR.
32752259	4	46	gly	glycoproteins	676:688	arg1	the major MGL-binding glycoproteins	the major MGL-binding glycoproteins				Fterm		glycoproteins			We had recently identified the major MGL-binding glycoproteins in two high-MGL-binding CRC cells lines, HCT116 and HT29.
33572881	6	52	gly	sialylated	985:994	arg1	several fucosylated and sialylated HMOs	several fucosylated and sialylated HMOs				OGER		HMOs	P00540		Maternal obesity was associated with lower concentrations of several fucosylated and sialylated HMOs and infants born to women with obesity had lower intakes of these HMOs.
33572881	6	57	gly	fucosylated	969:979	arg1	several fucosylated and sialylated HMOs	several fucosylated and sialylated HMOs				OGER		HMOs	P00540		Maternal obesity was associated with lower concentrations of several fucosylated and sialylated HMOs and infants born to women with obesity had lower intakes of these HMOs.
32862508	0	63	gly	fucosylated	67:77	arg1	fucosylated glycans				fucosylated glycans						Macrobrachium rosenbergii nodavirus virus-like particles attach to fucosylated glycans in the gills of the giant freshwater prawn.
34015001	2	26	gly	Factor	424:429	arg1	the pectin binding Wall associated Kinases	Factor (EGF			the pectin binding Wall associated Kinases	OGER		Factor (EGF	P01133		Cell adhesion in Arabidopsis may also be regulated through a pectin-related signaling cascade mediated by a putative O-fucosyltransferase ESMERALDA1 (ESMD1), and the Epidermal Growth Factor (EGF) domains of the pectin binding Wall associated Kinases (WAKs) are a primary candidate substrate for ESMD1 activity.
33821278	8	33	gly	glycosylation	1320:1332	arg2	Three incompletely occupied sites			Three incompletely occupied sites						sites	Three incompletely occupied sites of O-linked glycosylation were detected.
34065932	0	52	gly	Pectin	43:48	arg1	Residual Cell Wall Material	Pectin			Residual Cell Wall Material	Fterm		Pectin			The Structure and Composition of Extracted Pectin and Residual Cell Wall Material from Processing Tomato: The Role of a Stepwise Approach versus High-Pressure Homogenization-Facilitated Acid Extraction.
33125241	3	72	gly	glycopeptides	599:611	arg2	glycopeptides			glycopeptides						glycopeptides	Despite its utility, HILIC enrichment is associated with a number of shortcomings, including requiring large amounts of starting materials, potentially introducing chemical artifacts such as formylation when high concentrations of formic acid are used, and biasing/undersampling specific classes of glycopeptides.
33539901	5	15	gly	acids	1251:1255	arg1	rGth-hCTPs	rGth-hCTPs			acids	OGER		rGth-hCTPs	P17812		Further analyses of glycans by liquid chromatography-mass spectrometry suggested that the species, amount, and degree of sialylation of N-glycans were comparable among recombinant Fshs and recombinant Lhs, while the amount of O-glycans with sialic acids in rGth-hCTPs was higher than that in the corresponding rGth-eCTPs.
33539901	5	74	gly	sialylation	1124:1134	arg1	N-glycans				N-glycans						Further analyses of glycans by liquid chromatography-mass spectrometry suggested that the species, amount, and degree of sialylation of N-glycans were comparable among recombinant Fshs and recombinant Lhs, while the amount of O-glycans with sialic acids in rGth-hCTPs was higher than that in the corresponding rGth-eCTPs.
34013301	2	13	gly	protein	348:354	arg1	N-linked glycans	Spike protein			N-linked glycans	PUBTATOR		Spike protein	43740568		Cross-reactive antibodies specifically recognized the sialic acid moiety on N-linked glycans of the Spike protein and do not neutralize in vitro SARS-CoV-2.
33909078	1	34	gly	glycoproteins	287:299	arg1	glycoproteins	glycoproteins			N-	Fterm		glycoproteins			In the fission yeast Schizosaccharomyces pombe, α1,2- and α1,3-linked D-galactose (Gal) residues are transferred to N- and O-linked oligosaccharides of glycoproteins by galactosyltransferases.
33909078	1	34	gly	glycoproteins	287:299	arg1	glycoproteins	glycoproteins			O-linked oligosaccharides	Fterm		glycoproteins			In the fission yeast Schizosaccharomyces pombe, α1,2- and α1,3-linked D-galactose (Gal) residues are transferred to N- and O-linked oligosaccharides of glycoproteins by galactosyltransferases.
34712749	7	87	gly	glycoproteins	1324:1336	arg1	glycoproteins	glycoproteins			non-matured N-glycans	Fterm		glycoproteins			This allowed us to map the fraction of glycoproteins with non-matured N-glycans from A375 melanoma cells and find or validate N-glycosylation sites of proteins from the secretory pathway.
34712749	7	78	gly	N-glycosylation	1411:1425	arg2	N-glycosylation sites	proteins		sites		Fterm		proteins		sites	This allowed us to map the fraction of glycoproteins with non-matured N-glycans from A375 melanoma cells and find or validate N-glycosylation sites of proteins from the secretory pathway.
34318377	2	45	gly	used	518:521	arg2	The resultant composite			The resultant composite						composite	The resultant composite was used as an effective and novel sorbent for pipette-tip micro-solid phase extraction (PT-μSPE) of seven opioid analgesics (OAs) in biological samples followed by HPLC-UV analysis.
33535571	4	59	gly	α2,3-/α2,6-sialylated	955:975	arg1	α2,3-/α2,6-sialylated structures				α2,3-/α2,6-sialylated structures						In total, 62 N-glycan isomers spanning 41 glycan compositions primarily comprising complex-type core fucosylated, bisecting N-acetylglucosamine (GlcNAc), and α2,3-/α2,6-sialylated structures were profiled across all samples using label-free quantitation.
33404253	6	91	gly	N-glycosylation	1320:1334	arg2	N-glycosylation motifs			N-glycosylation motifs						motifs	The comparative glycoproteomic analysis of B. alcatraz venom with B. jararaca and B. insularis indicated that there may be differences in the utilization of N-glycosylation motifs among their different toxin classes.
32065575	7	38	gly	had	614:616	arg1	The strain AND cell wall peptidoglycan type A3α l-Lys-Gly	The strain			cell wall peptidoglycan type A3α l-Lys-Gly	Fterm		strain			The strain had cell wall peptidoglycan type A3α l-Lys-Gly.
32376684	3	58	gly	N-glycosylation	595:609	arg2	N-glycosylation sites			N-glycosylation sites						sites	Here, we identified N-glycosylation sites in mouse EOGT and elucidated their molecular functions.
32885670	1	43	gly	used	170:173	arg2	The carbon isotopic composition			The carbon isotopic composition						position	The carbon isotopic composition (δ13C) of foliage is often used as proxy for plant performance.
33149259	0	39	gly	glycoforms	33:42	arg1	the main PSA glycoforms	the main PSA glycoforms				PUBTATOR		PSA	354		Characterisation of the main PSA glycoforms in aggressive prostate cancer.
33942129	1	51	gly	glycoproteins	181:193	arg1	N-linked and O-linked glycoproteins	N-linked and O-linked glycoproteins				Fterm		glycoproteins			BACKGROUND Galectins are proteins that bind β-galactosides such as N-acetyllactosamine present in N-linked and O-linked glycoproteins and that seem to be implicated in inflammatory and immune responses as well as fibrotic mechanisms.
33942129	1	55	gly	present	148:154	arg1	N-linked and O-linked glycoproteins AND N-acetyllactosamine	N-linked and O-linked glycoproteins			N-acetyllactosamine	Fterm		glycoproteins			BACKGROUND Galectins are proteins that bind β-galactosides such as N-acetyllactosamine present in N-linked and O-linked glycoproteins and that seem to be implicated in inflammatory and immune responses as well as fibrotic mechanisms.
34602421	2	39	gly	composition	372:382	arg1	Crude Monkshood Polysaccharide			position	Crude Monkshood Polysaccharide					position	In the present study, Crude Monkshood Polysaccharide (CMP), another one natural composition component originated from the same herbal with aconitine, combined with aconitine to investigate the effects on HCC and immunity in vitro and in vivo.
31924694	6	10	gly	N-glycopeptides	1295:1309	arg2	these N-glycopeptides			these N-glycopeptides						N-glycopeptides	Comparison of these N-glycopeptides revealed striking differences in protein N-glycosylation between sexes.
32841408	2	45	gly	Glycosylation	238:250	arg1	rhuEPO	rhuEPO				Cterm		rhuEPO	2056		Glycosylation of rhuEPO was crucial for affecting biological activity, immunogenicity, and pharmacokinetics.
33090600	0	12	gly	Impact	100:105	arg1	a Lewis X Type DC-SIGN Ligand	Impact			a Lewis X Type DC-SIGN Ligand	OGER		Impact	Q9P2X3		Synthesis of Asparagine Derivatives Harboring a Lewis X Type DC-SIGN Ligand and Evaluation of their Impact on Immunomodulation in Multiple Sclerosis.
32459612	5	7	gly	sialylated	1099:1108	arg1	the sialylated receptor	the sialylated receptor				Fterm		receptor			Virus infectivity data from RP19 cells treated with sodium periodate, proteases (trypsin or bromelain) or metabolic inhibitors (dl-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol, tunicamycin, or benzyl N-acetyl-α-d-galactosaminide) indicated that N-linked, but not O-linked, carbohydrates are part of the sialylated receptor and they are likely based on a membrane glycoprotein, rather than a glycolipid.
32459612	5	11	gly	glycoprotein	1159:1170	arg1	a membrane glycoprotein	a membrane glycoprotein				Fterm		glycoprotein			Virus infectivity data from RP19 cells treated with sodium periodate, proteases (trypsin or bromelain) or metabolic inhibitors (dl-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol, tunicamycin, or benzyl N-acetyl-α-d-galactosaminide) indicated that N-linked, but not O-linked, carbohydrates are part of the sialylated receptor and they are likely based on a membrane glycoprotein, rather than a glycolipid.
32459612	5	70	gly	receptor	1110:1117	arg1	N-linked, but not O-linked, carbohydrates	receptor			N-linked, but not O-linked, carbohydrates	Fterm		receptor			Virus infectivity data from RP19 cells treated with sodium periodate, proteases (trypsin or bromelain) or metabolic inhibitors (dl-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol, tunicamycin, or benzyl N-acetyl-α-d-galactosaminide) indicated that N-linked, but not O-linked, carbohydrates are part of the sialylated receptor and they are likely based on a membrane glycoprotein, rather than a glycolipid.
32195245	2	33	gly	Glycosylation	207:219	arg1	the IgG fragment crystallizable (Fc) region			the IgG fragment crystallizable (Fc) region						region	Glycosylation of the IgG fragment crystallizable (Fc) region is shown to vary in different physiological and pathological states.
33821278	5	85	gly	glycoprotein	793:804	arg1	a wild-type SARS-CoV-2 S glycoprotein trimer	a wild-type SARS-CoV-2 S glycoprotein trimer				PUBTATOR		S glycoprotein	43740568		We used a fucose-selective lectin to enrich the Golgi-resident fraction of a wild-type SARS-CoV-2 S glycoprotein trimer, and determined its glycosylation and disulfide bond profile.
33363672	4	57	gly	glycopeptide	653:664	arg2	a robust glycopeptide detection			a robust glycopeptide detection						glycopeptide	Here, a selection of these tools was combined and evaluated with the aim of establishing a robust glycopeptide detection and quantification workflow targeting enriched glycoproteins.
33363672	4	99	gly	glycoproteins	723:735	arg1	workflow targeting enriched glycoproteins	workflow targeting enriched glycoproteins				Fterm		glycoproteins			Here, a selection of these tools was combined and evaluated with the aim of establishing a robust glycopeptide detection and quantification workflow targeting enriched glycoproteins.
33149259	4	45	gly	sialylated	616:625	arg1	the main sialylated PSA glycoforms				the main sialylated PSA glycoforms						In this study, we have characterised the main sialylated PSA glycoforms from blood serum of aggressive PCa patients and have compared with those of standard PSA from healthy individuals' seminal plasma.
33149259	4	60	gly	glycoforms	631:640	arg1	the main sialylated PSA glycoforms				the main sialylated PSA glycoforms						In this study, we have characterised the main sialylated PSA glycoforms from blood serum of aggressive PCa patients and have compared with those of standard PSA from healthy individuals' seminal plasma.
33539901	4	18	gly	sialylated	965:974	arg1	highly sialylated O-linked oligosaccharides				highly sialylated O-linked oligosaccharides						In contrast, only rGth-hCTPs and rGth-eCTPs possessed highly sialylated O-linked oligosaccharides.
33539901	4	8	gly	possessed	948:956	arg1	rGth-hCTPs AND highly sialylated O-linked oligosaccharides	rGth-hCTPs			highly sialylated O-linked oligosaccharides	OGER		rGth-hCTPs	P17812		In contrast, only rGth-hCTPs and rGth-eCTPs possessed highly sialylated O-linked oligosaccharides.
32781127	10	12	gly	occupied	2368:2375	arg2	the bone defect site			the bone defect site						site	Microscopic computed tomography (micro-CT) results demonstrated that the bone defect site was nearly occupied with newly formed bone at 12 weeks after implantation of EHSS/HAp with 70% SPI content into the defect.
34684428	3	101	gly	glycoproteins	661:673	arg1	glycoproteins	glycoproteins				Fterm		glycoproteins			Therefore, the main objective of the proposed research is to investigate how the intestinal microbiota of preterm and full-term infants differ in their ability to extract energy and nutrients from oligosaccharides and glycoproteins in human milk.
31961287	5	71	gly	anteiso-C15 	811:822	arg1	anteiso-C17 			anteiso-C17 				nov	Q9UIW2	C17 	The peptidoglycan contains meso-diaminopimelic acid (mDAP) and the predominant fatty acids are anteiso-C15 : 0 (61.9 %) and anteiso-C17 : 0 (11.6 %), confirming that strain MS2379T has diagnostic features of other Paenibacillus species.
33301522	5	55	gly	N-glycopeptides	1197:1211	arg2	intact N-glycopeptides			intact N-glycopeptides						N-glycopeptides	Finally, we found that the combination of Trypsin (B)/Lys-C digestion and zwitterionic HILIC (Zic-HILIC) enrichment significantly improved the mass spectrometric characterization of intact N-glycopeptides, increasing the number of identified intact N-glycopeptides and offering better analytical reproducibility.
33301522	5	70	gly	N-glycopeptides	1257:1271	arg2	identified intact N-glycopeptides			identified intact N-glycopeptides						N-glycopeptides	Finally, we found that the combination of Trypsin (B)/Lys-C digestion and zwitterionic HILIC (Zic-HILIC) enrichment significantly improved the mass spectrometric characterization of intact N-glycopeptides, increasing the number of identified intact N-glycopeptides and offering better analytical reproducibility.
35126378	7	32	gly	D-Ala	1236:1240	arg1	D-Ala L. plantarum peptidoglycan precursors			Ala	D-Ala L. plantarum peptidoglycan precursors					Ala	We further explored the regulation of the macrophage inflammatory response pathway by the wild-type and constructed strains, and found that these strains induced the MyD88-dependent TRAF6/MAPK pathway, and the increase in D-Ala L. plantarum peptidoglycan precursors increased the secretion of the inflammatory factors IL-6, IL-1β and TNF-α.
34360993	8	51	gly	found	1118:1122	arg1	the canonical four N-glycosylation sites AND HexNAc2Hex11			the canonical four N-glycosylation sites	HexNAc2Hex11					sites	Glycan analysis indicates that predominant glycoforms HexNAc2Hex8 and HexNAc2Hex11 are found at Asn119, Asn378, and Asn743, three of the canonical four N-glycosylation sites of human CP.
34360993	8	51	gly	found	1118:1122	arg2	the canonical four N-glycosylation sites AND HexNAc2Hex8			the canonical four N-glycosylation sites	HexNAc2Hex8					sites	Glycan analysis indicates that predominant glycoforms HexNAc2Hex8 and HexNAc2Hex11 are found at Asn119, Asn378, and Asn743, three of the canonical four N-glycosylation sites of human CP.
34360993	8	51	gly	found	1118:1122	arg1	Asn119 AND HexNAc2Hex11			Asn119, Asn378, and Asn743	HexNAc2Hex11			Ceruloplasmin	1356	Asn119, Asn378, and Asn743	Glycan analysis indicates that predominant glycoforms HexNAc2Hex8 and HexNAc2Hex11 are found at Asn119, Asn378, and Asn743, three of the canonical four N-glycosylation sites of human CP.
34360993	8	51	gly	found	1118:1122	arg1	Asn378 AND HexNAc2Hex11			Asn119, Asn378, and Asn743	HexNAc2Hex11			Ceruloplasmin	1356	Asn119, Asn378, and Asn743	Glycan analysis indicates that predominant glycoforms HexNAc2Hex8 and HexNAc2Hex11 are found at Asn119, Asn378, and Asn743, three of the canonical four N-glycosylation sites of human CP.
34360993	8	51	gly	found	1118:1122	arg1	Asn378 AND HexNAc2Hex11			Asn119, Asn378, and Asn743	HexNAc2Hex11			Ceruloplasmin	1356	Asn119, Asn378, and Asn743	Glycan analysis indicates that predominant glycoforms HexNAc2Hex8 and HexNAc2Hex11 are found at Asn119, Asn378, and Asn743, three of the canonical four N-glycosylation sites of human CP.
34360993	8	51	gly	found	1118:1122	arg2	Asn119 AND HexNAc2Hex8			Asn119, Asn378, and Asn743	HexNAc2Hex8			Ceruloplasmin	1356	Asn119, Asn378, and Asn743	Glycan analysis indicates that predominant glycoforms HexNAc2Hex8 and HexNAc2Hex11 are found at Asn119, Asn378, and Asn743, three of the canonical four N-glycosylation sites of human CP.
34360993	8	51	gly	found	1118:1122	arg2	Asn378 AND HexNAc2Hex8			Asn119, Asn378, and Asn743	HexNAc2Hex8			Ceruloplasmin	1356	Asn119, Asn378, and Asn743	Glycan analysis indicates that predominant glycoforms HexNAc2Hex8 and HexNAc2Hex11 are found at Asn119, Asn378, and Asn743, three of the canonical four N-glycosylation sites of human CP.
34360993	8	51	gly	found	1118:1122	arg2	Asn378 AND HexNAc2Hex8			Asn119, Asn378, and Asn743	HexNAc2Hex8			Ceruloplasmin	1356	Asn119, Asn378, and Asn743	Glycan analysis indicates that predominant glycoforms HexNAc2Hex8 and HexNAc2Hex11 are found at Asn119, Asn378, and Asn743, three of the canonical four N-glycosylation sites of human CP.
34360993	8	72	gly	N-glycosylation	1183:1197	arg1	human CP	CP		sites		PUBTATOR		CP	1356	sites	Glycan analysis indicates that predominant glycoforms HexNAc2Hex8 and HexNAc2Hex11 are found at Asn119, Asn378, and Asn743, three of the canonical four N-glycosylation sites of human CP.
34298952	8	69	gly	glycoproteins	1606:1618	arg1	the identified glycoproteins	the identified glycoproteins				Fterm		glycoproteins			STRING bioinformatics analysis linked the identified glycoproteins in the close network, indicating their involvement in immune (partially innate) processes.
34482828	6	135	gly	glycosylation	1317:1329	arg2	approximately 12 O-linked glycosylation sites			approximately 12 O-linked glycosylation sites						sites	However, the secretion of eCGβ-D/α and eCGβ-D/αΔ56, which lack approximately 12 O-linked glycosylation sites, was slightly delayed.
34863837	4	48	gly	glycosylated	744:755	arg1	the protein	the protein				Fterm		protein			High-resolution LC-MS analysis indicated that the protein is heterogeneously glycosylated and also contains multiple acetylations, occurring in the attached glycans.
33480676	2	9	gly	glycoprotein	517:528	arg1	fetuin	fetuin				OGER		fetuin, a	P02765		Taking advantage of boronic acid (BA) based SA-recognition chemistry, we here demonstrate a label-free, no enzymatic, potentiometric determination of fetuin, a blood-circulating glycoprotein implicated in physiological and various pathological states.
33480676	2	9	gly	glycoprotein	517:528	arg1	a blood-circulating glycoprotein	a blood-circulating glycoprotein				Fterm		glycoprotein			Taking advantage of boronic acid (BA) based SA-recognition chemistry, we here demonstrate a label-free, no enzymatic, potentiometric determination of fetuin, a blood-circulating glycoprotein implicated in physiological and various pathological states.
33301522	3	29	gly	N-glycopeptides	648:662	arg2	identified intact N-glycopeptides			identified intact N-glycopeptides						N-glycopeptides	However, the number of identified intact N-glycopeptides remains inadequate to achieve an in-depth profile of the N-glycosylation landscape.
33090600	4	22	gly	asparagine	654:663	arg1	an unnatural Lewis X (LeX )-containing Fmoc-SPPS-compatible asparagine building block			asparagine	an unnatural Lewis X (LeX )-containing Fmoc-SPPS-compatible asparagine building block					asparagine	Here, we report the synthesis of an unnatural Lewis X (LeX )-containing Fmoc-SPPS-compatible asparagine building block (SPPS=solid-phase peptide synthesis), as well as asparagine building blocks containing two LeX -derived oligosaccharides: LacNAc and Fucα1-3GlcNAc.
33090600	4	59	gly	peptide	698:704	arg1	an unnatural Lewis X (LeX )-containing Fmoc-SPPS-compatible asparagine building block				an unnatural Lewis X (LeX )-containing Fmoc-SPPS-compatible asparagine building block						Here, we report the synthesis of an unnatural Lewis X (LeX )-containing Fmoc-SPPS-compatible asparagine building block (SPPS=solid-phase peptide synthesis), as well as asparagine building blocks containing two LeX -derived oligosaccharides: LacNAc and Fucα1-3GlcNAc.
31830181	4	1	gly	used	807:810	arg2	the designed nanocomposite			the designed nanocomposite						nanocomposite	Based on these features, the designed nanocomposite was used as a signal transducer to develop a colorimetric assay and multicolor imaging for accurate and sensitive detection of cancer cells.
33821278	3	91	gly	glycoprotein	389:400	arg1	the SARS-CoV-2 S glycoprotein	the SARS-CoV-2 S glycoprotein				PUBTATOR		S glycoprotein	43740568		Approximately 35% of the SARS-CoV-2 S glycoprotein consists of carbohydrate, which can influence virus infectivity and susceptibility to antibody inhibition.
33038510	10	41	gly	glycoproteins	1837:1849	arg1	glycoproteins	glycoproteins				Fterm		glycoproteins			Glycan alterations on glycoconjugates, such as glycoproteins have emerged as a rich source for the identification of novel cancer markers.
33038510	10	98	gly	alterations	1797:1807	arg1	glycoproteins	glycoproteins			alterations	Fterm		glycoproteins			Glycan alterations on glycoconjugates, such as glycoproteins have emerged as a rich source for the identification of novel cancer markers.
31931062	7	14	gly	glycoprotein	1122:1133	arg1	transferrin	transferrin				OGER		transferrin	P02787		Isothermal calorimetry showed that compared with rHEL1, rSHL1 interacted more strongly with transferrin, a fucosylated glycoprotein, than with other fucosylated disaccharide glycoconjugates.
31931062	7	14	gly	glycoprotein	1122:1133	arg1	a fucosylated glycoprotein	a fucosylated glycoprotein				Fterm		glycoprotein			Isothermal calorimetry showed that compared with rHEL1, rSHL1 interacted more strongly with transferrin, a fucosylated glycoprotein, than with other fucosylated disaccharide glycoconjugates.
31931062	7	34	gly	fucosylated	1152:1162	arg1	other fucosylated disaccharide glycoconjugates				other fucosylated disaccharide glycoconjugates						Isothermal calorimetry showed that compared with rHEL1, rSHL1 interacted more strongly with transferrin, a fucosylated glycoprotein, than with other fucosylated disaccharide glycoconjugates.
31931062	7	44	gly	fucosylated	1110:1120	arg1	transferrin	transferrin				OGER		transferrin	P02787		Isothermal calorimetry showed that compared with rHEL1, rSHL1 interacted more strongly with transferrin, a fucosylated glycoprotein, than with other fucosylated disaccharide glycoconjugates.
31931062	7	44	gly	fucosylated	1110:1120	arg1	a fucosylated glycoprotein	a fucosylated glycoprotein				Fterm		glycoprotein			Isothermal calorimetry showed that compared with rHEL1, rSHL1 interacted more strongly with transferrin, a fucosylated glycoprotein, than with other fucosylated disaccharide glycoconjugates.
34959902	6	76	gly	biosynthesis	1330:1341	arg1	pigs	pigs			biosynthesis	OGER		pigs	Q96S52		Linear discriminant analysis effect size (LEfSe) in fecal microbiome samples showed differential increases in genera from Lachnospiraceae and Ruminococcaceae families within the order Clostridiales and Erysipelotrichaceae family with a predicted reduction in rgpE-glucosyltransferase protein associated with lipopolysaccharide biosynthesis in pigs fed the FV-supplemented diet.
34904944	7	21	gly	IMT-300T	839:846	arg1	The peptidoglycan	IMT-300T			The peptidoglycan	Cterm		IMT-300T			The peptidoglycan of strain IMT-300T contained l-2,4-diaminobutyric acid as the diagnostic diamino acid.
34298952	2	34	gly	glycoproteins	490:502	arg1	Seminal plasma glycoproteins	Seminal plasma glycoproteins				Fterm		glycoproteins			Seminal plasma glycoproteins are rich in the unique immunomodulatory glycoepitopes that may serve as ligands for endogenous lectins that decorate the surface of immune cells.
32459612	0	52	gly	acid	49:52	arg1	N-linked glycoproteins	glycoproteins			acid	Fterm		glycoproteins			Turkey adenovirus 3, a siadenovirus, uses sialic acid on N-linked glycoproteins as a cellular receptor.
32459612	0	71	gly	glycoproteins	66:78	arg1	N-linked glycoproteins	N-linked glycoproteins				Fterm		glycoproteins			Turkey adenovirus 3, a siadenovirus, uses sialic acid on N-linked glycoproteins as a cellular receptor.
33100848	1	18	gly	composites	141:150	arg1	Plants polysaccharides			composites	Plants polysaccharides					composites	Plants polysaccharides are an infinite stock of drug composites with varying pharmacological and biological activities.
32131144	7	65	gly	proteins	1012:1019	arg1	poly(I:C)/D-GalN	proteins			poly(I:C)/D-GalN	Fterm		proteins			Among 80,195, and 23 specifically-expressed proteins in poly(I:C)/D-GalN, LPS/D-GalN, and CpG DNA/D-GalN groups, LPS/D-GalN-specific proteins are mostly distributed in the endoplasmic reticulum and more enriched in metabolic pathways, whereas poly (I:C)/D-GalN-specific proteins are mainly in the membrane and CpG DNA/D-GalN-specific proteins are related to the ribosome structural composition.
32131144	7	65	gly	proteins	1012:1019	arg1	CpG DNA/D-GalN groups	proteins			CpG DNA/D-GalN groups	Fterm		proteins			Among 80,195, and 23 specifically-expressed proteins in poly(I:C)/D-GalN, LPS/D-GalN, and CpG DNA/D-GalN groups, LPS/D-GalN-specific proteins are mostly distributed in the endoplasmic reticulum and more enriched in metabolic pathways, whereas poly (I:C)/D-GalN-specific proteins are mainly in the membrane and CpG DNA/D-GalN-specific proteins are related to the ribosome structural composition.
32131144	7	65	gly	proteins	1012:1019	arg1	LPS/D-GalN	proteins			LPS/D-GalN	Fterm		proteins			Among 80,195, and 23 specifically-expressed proteins in poly(I:C)/D-GalN, LPS/D-GalN, and CpG DNA/D-GalN groups, LPS/D-GalN-specific proteins are mostly distributed in the endoplasmic reticulum and more enriched in metabolic pathways, whereas poly (I:C)/D-GalN-specific proteins are mainly in the membrane and CpG DNA/D-GalN-specific proteins are related to the ribosome structural composition.
32123275	7	30	gly	GH10	1449:1452	arg1	Xyl10E	GH10			Xyl10E	Cterm		GH10			To further investigate the termite microbiomes as sources of biotechnologically relevant glycosyl hydrolases, a putative GH10 endo-β-1,4-xylanase, Xyl10E, was cloned and expressed in Escherichia coli.
31931062	6	75	gly	fucosylated	909:919	arg1	fucosylated N-glycans				fucosylated N-glycans						A glycan-array analysis revealed that the two recombinant lectins had different binding intensities toward fucosylated N-glycans harboring fucose-α(1,2) galactose or fucose-α(1,4) N-acetylglucosamine.
31463900	1	45	gly	modified	231:238	arg3	Metalloproteinases AND glycan moieties	Metalloproteinases			glycan moieties	Fterm		Metalloproteinases			Metalloproteinases of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin type 1 repeats) superfamily are extensively modified with glycan moieties.
33090600	3	6	gly	MOG	505:507	arg1	the N-glycan	MOG			the N-glycan	OGER		MOG	Q16653		This is mediated by the interaction of Lewis-type glycan structures in the N-glycan of MOG with the DC-SIGN receptor on dendritic cells (DCs).
32376684	2	72	gly	presence	499:506	arg1	EOGT AND N-glycans	EOGT			N-glycans	PUBTATOR		EOGT	285203		Several EOGT mutations that may affect putative N-glycosylation consensus sites are recorded in the cancer database, but the presence and function of N-glycans in EOGT have not yet been characterized.
32376684	2	76	gly	N-glycosylation	422:436	arg2	putative N-glycosylation consensus sites			putative N-glycosylation consensus sites						sites	Several EOGT mutations that may affect putative N-glycosylation consensus sites are recorded in the cancer database, but the presence and function of N-glycans in EOGT have not yet been characterized.
33090600	1	9	gly	glycoprotein	185:196	arg1	The protein myelin oligodendrocyte glycoprotein	The protein myelin oligodendrocyte glycoprotein				OGER		myelin oligodendrocyte glycoprotein	Q16653		The protein myelin oligodendrocyte glycoprotein (MOG) is a key component of myelin and an autoantigen in the disease multiple sclerosis (MS).
33090600	1	9	gly	glycoprotein	185:196	arg1	MOG	MOG				OGER		MOG	Q16653		The protein myelin oligodendrocyte glycoprotein (MOG) is a key component of myelin and an autoantigen in the disease multiple sclerosis (MS).
33807002	9	47	gly	N-acetyl-glycoprotein	1611:1631	arg1	N-acetyl-glycoprotein	N-acetyl-glycoprotein				PUBTATOR		N-acetyl-glycoprotein	4669		RESULTS Three metabolites were identified as potential biomarkers: betaine, N-acetyl-glycoprotein, and carnitine.
31928547	0	59	gly	composition	73:83	arg1	lipopolysaccharide-challenged pigs			position	lipopolysaccharide-challenged pigs					position	Holly polyphenols alleviate intestinal inflammation and alter microbiota composition in lipopolysaccharide-challenged pigs.
33127381	6	41	gly	α1,2-fucosylated	859:874	arg1	CRS1	CRS1		sequence		PUBTATOR		CRS1	7291	sequence	In particular, cryptdin-related sequence 1 (CRS1) expressed in Paneth cells was found to be α1,2-fucosylated.
33127381	5	7	gly	glycopeptides	752:764	arg2	3212 O-linked and 2962 N-linked glycopeptides			3212 O-linked and 2962 N-linked glycopeptides						glycopeptides	Glycoproteomic analysis of ileal lysates identified 3212 O-linked and 2962 N-linked glycopeptides.
34712749	8	62	gly	glycoproteins	1514:1526	arg1	glycoproteins	glycoproteins				Fterm		glycoproteins			The same dataset was also used to define glycoproteins altered by the down-regulation of endogenous EDEM2, which should contain its candidate-substrates.
32678209	3	33	gly	glycoprotein	569:580	arg1	glycoprotein structures	glycoprotein structures				Fterm		glycoprotein			We analyze here the utilization of four disaccharides, lacto-N-biose (LNB), galacto-N-biose (GNB), fucosyl-α1,3-GlcNAc (3FN) and fucosyl-α1,6-GlcNAc (6FN), that form part of HMOs and glycoprotein structures, by the infant fecal microbiota.
32777429	2	49	gly	used	379:382	arg2	The anionic polypeptide			The anionic polypeptide						polypeptide	The anionic polypeptide, poly-γ-glutamic acid (PG) and the glycosaminoglycan, hyaluronic acid, were used to stabilize ACZ-NS prepared using the antisolvent precipitation (AS-PT) coupled with sonication technique.
32777429	2	49	gly	used	379:382	arg2	poly-γ-glutamic acid			poly-γ-glutamic acid						glutamic acid	The anionic polypeptide, poly-γ-glutamic acid (PG) and the glycosaminoglycan, hyaluronic acid, were used to stabilize ACZ-NS prepared using the antisolvent precipitation (AS-PT) coupled with sonication technique.
32353494	4	68	gly	asialoglycoprotein	605:622	arg1	asialoglycoprotein receptor	asialoglycoprotein receptor				PUBTATOR		asialoglycoprotein receptor	432		Galactose ligands could bind to the asialoglycoprotein receptor (ASGPR) on the surface of hepatocytes.
33821278	0	77	gly	glycoprotein	78:89	arg1	glycoprotein	glycoprotein				PUBTATOR		spike glycoprotein	43740568		Analysis of glycosylation and disulfide bonding of wild-type SARS-CoV-2 spike glycoprotein.
34279376	7	54	gly	used	1263:1266	arg2	The algal biocomposite			The algal biocomposite						biocomposite	The algal biocomposite obtained according to our procedure can be used also as a prebiotic supplement.
33125241	2	2	gly	glycopeptide	191:202	arg2	Hydrophilic interaction liquid chromatography (HILIC) glycopeptide enrichment			Hydrophilic interaction liquid chromatography (HILIC) glycopeptide enrichment						glycopeptide	Hydrophilic interaction liquid chromatography (HILIC) glycopeptide enrichment is an indispensable tool for the high-throughput characterization of glycoproteomes.
33363672	11	72	gly	glycopeptide	1880:1891	arg2	MS/MS- and MS1-based glycopeptide identification			MS/MS- and MS1-based glycopeptide identification						glycopeptide	Finally, this study presents a semiautomated workflow for reliable glycoproteomic data analysis by the combination of software packages for MS/MS- and MS1-based glycopeptide identification as well as the integration of analyte quality control and quantification.
33038510	11	67	gly	glycoproteins	2052:2064	arg1	those glycoproteins	those glycoproteins				Fterm		glycoproteins			In the present work, we aimed to shed light on novel biomarkers based on altered glycosylation in PDA, in particular those glycoproteins of PDA tissues carrying the tumor carbohydrate antigen sialyl-Lewis x (sLex).
33038510	12	117	gly	glycoprotein	2202:2213	arg1	the glycoprotein MFAP4	the glycoprotein MFAP4				Fterm		glycoprotein			Through a glycoproteomic approach, we have shown that the glycoprotein MFAP4 carries sLex in PDA tissues and not in control pancreatic tissues.
32862508	5	62	gly	glycoproteins	990:1002	arg1	gill glycoproteins	gill glycoproteins				Fterm		glycoproteins			The broad, fucose-binding Aleuria Aurantia lectin (AAL) highly reduced MrNV-VLPs binding to gill tissue sections and lysates, and efficiently disrupted the specific interactions between the VLPs and gill glycoproteins.
34013301	0	4	gly	epitopes	71:78	arg1	the SARS-CoV-2 Spike protein	Spike protein			epitopes	PUBTATOR		Spike protein	43740568		Plasmodium infection induces cross-reactive antibodies to carbohydrate epitopes on the SARS-CoV-2 Spike protein.
32996878	11	26	gly	C16 	1917:1920	arg1	C19 			C19 				nov	Q9UIW2	C19 	Peptidoglycan type of strain TMW 2.1615T is Lys-Ala and major fatty acids are C16 : 0, C19 : 0cyclo ω8c and summed feature 8.
33068039	1	33	gly	glycoprotein	195:206	arg1	its envelope glycoprotein	its envelope glycoprotein				PUBTATOR		envelope glycoprotein	100616444		Machupo virus, known to cause hemorrhagic fevers, enters human cells via binding with its envelope glycoprotein to transferrin receptor 1 (TfR).
31924694	11	36	gly	N-glycosylation	2040:2054	arg2	N-glycosylation sites			N-glycosylation sites						sites	Furthermore, original data on N-glycosylation sites of N. lugens adults are presented, providing novel insights into planthopper's biology and information for future biological pest control strategies.
32376684	1	87	gly	receptors	298:306	arg1	EGF repeats	Notch receptors			EGF repeats	PUBTATOR		Notch receptors	4851		Epidermal growth factor (EGF) domain-specific O-GlcNAc transferase (EOGT) is an endoplasmic reticulum (ER)-resident protein that modifies EGF repeats of Notch receptors and thereby regulates Delta-like ligand-mediated Notch signaling.
33517204	9	80	gly	used	1111:1114	arg2	This nanocomposite			This nanocomposite						nanocomposite	This nanocomposite was used to increase the antibody loading and accelerate the electron transfer, which can increase the biosensor sensitivity.
33301522	8	27	gly	N-glycosylated	1853:1866	arg1	N-glycosylated proteins	N-glycosylated proteins				Fterm		proteins			This study also provides an interesting comparison of the N-glycoproteome of breast cancer cells cultured in different growth conditions, indicating the important role of N-glycosylated proteins in cancer cell growth and the choice of the cell culture model for studies in tumor biology and drug evaluation.
33295623	6	35	gly	α-O-GalNAc-threonine	1066:1085	arg1	the α-O-GalNAc-threonine residue			threonine residue	the α-O-GalNAc-threonine residue					threonine residue	Further examination of the NMR-based structure and the MD results suggest a more extensive network of hydrogen bond interactions within the α-O-GalNAc-threonine residue than has been previously appreciated, which influences the properties of the protein backbone.
35141446	9	2	gly	glycosylation	1586:1598	arg2	specific glycosylation sites			specific glycosylation sites						sites	These results provide important information on rec-eCG in the regulation of specific glycosylation sites and improve our understanding of the specific biological activity of rec-eCG glycosylation sites in equidaes.
35141446	9	79	gly	glycosylation	1683:1695	arg2	rec-eCG glycosylation sites			rec-eCG glycosylation sites						sites	These results provide important information on rec-eCG in the regulation of specific glycosylation sites and improve our understanding of the specific biological activity of rec-eCG glycosylation sites in equidaes.
34366479	5	20	gly	found	791:795	arg1	HSRP-2 AND Varied monosaccharide compositions	HSRP-2			Varied monosaccharide compositions	OGER		HSRP	Q96RP3		Varied monosaccharide compositions were found in FSRP-1, FSRP-2, HSRP-1 and HSRP-2, and HAD-treated SRP had more glucose and less galactose.
34366479	5	20	gly	found	791:795	arg1	HSRP-1 AND Varied monosaccharide compositions	HSRP-1			Varied monosaccharide compositions	PUBTATOR		HSRP-1	3839		Varied monosaccharide compositions were found in FSRP-1, FSRP-2, HSRP-1 and HSRP-2, and HAD-treated SRP had more glucose and less galactose.
34366479	5	20	gly	found	791:795	arg1	FSRP-1 AND Varied monosaccharide compositions	FSRP			Varied monosaccharide compositions	PUBTATOR		FSRP	10272		Varied monosaccharide compositions were found in FSRP-1, FSRP-2, HSRP-1 and HSRP-2, and HAD-treated SRP had more glucose and less galactose.
34482828	2	36	gly	glycosylation	586:598	arg2	the following glycosylation site mutants			the following glycosylation site mutants						site	To examine the biological function of glycosylated sites in eCG, the following glycosylation site mutants were constructed: eCGβ/αΔ56, substitution of Asn56 of α-subunit with Gln; eCGβ-D/α, deletion of the O-linked glycosylation site at the carboxyl-terminal peptide (CTP) region of the β-subunit; eCGβ-D/αΔ56, double mutant.
34482828	2	111	gly	glycosylated	545:556	arg1	glycosylated sites			glycosylated sites						sites	To examine the biological function of glycosylated sites in eCG, the following glycosylation site mutants were constructed: eCGβ/αΔ56, substitution of Asn56 of α-subunit with Gln; eCGβ-D/α, deletion of the O-linked glycosylation site at the carboxyl-terminal peptide (CTP) region of the β-subunit; eCGβ-D/αΔ56, double mutant.
34482828	2	132	gly	glycosylation	722:734	arg2	the O-linked glycosylation site			the O-linked glycosylation site						site	To examine the biological function of glycosylated sites in eCG, the following glycosylation site mutants were constructed: eCGβ/αΔ56, substitution of Asn56 of α-subunit with Gln; eCGβ-D/α, deletion of the O-linked glycosylation site at the carboxyl-terminal peptide (CTP) region of the β-subunit; eCGβ-D/αΔ56, double mutant.
34482828	2	132	gly	glycosylation	722:734	arg2	the carboxyl-terminal peptide (CTP) region			the carboxyl-terminal peptide (CTP) region						region	To examine the biological function of glycosylated sites in eCG, the following glycosylation site mutants were constructed: eCGβ/αΔ56, substitution of Asn56 of α-subunit with Gln; eCGβ-D/α, deletion of the O-linked glycosylation site at the carboxyl-terminal peptide (CTP) region of the β-subunit; eCGβ-D/αΔ56, double mutant.
32152415	4	11	gly	hypo-sialylated	825:839	arg1	the pro-inflammatory hypo-sialylated T-antigen glycans				the pro-inflammatory hypo-sialylated T-antigen glycans						In particular, high levels of the pro-inflammatory hypo-sialylated T-antigen glycans and low levels of the anti-inflammatory fucosylated glycans were associated with higher abundance of glycan-degrading microbial species (in particular, Bacteroides vulgatus), a less diverse microbiome, higher levels of inflammation, and higher levels of ileum-associated HIV DNA.
32152415	4	15	gly	pro-inflammatory	808:823	arg1	the pro-inflammatory hypo-sialylated T-antigen glycans			pro	the pro-inflammatory hypo-sialylated T-antigen glycans					pro	In particular, high levels of the pro-inflammatory hypo-sialylated T-antigen glycans and low levels of the anti-inflammatory fucosylated glycans were associated with higher abundance of glycan-degrading microbial species (in particular, Bacteroides vulgatus), a less diverse microbiome, higher levels of inflammation, and higher levels of ileum-associated HIV DNA.
32152415	4	49	gly	fucosylated	899:909	arg1	the anti-inflammatory fucosylated glycans				the anti-inflammatory fucosylated glycans						In particular, high levels of the pro-inflammatory hypo-sialylated T-antigen glycans and low levels of the anti-inflammatory fucosylated glycans were associated with higher abundance of glycan-degrading microbial species (in particular, Bacteroides vulgatus), a less diverse microbiome, higher levels of inflammation, and higher levels of ileum-associated HIV DNA.
34196604	4	43	gly	observed	435:442	arg1	anteiso-C17 			anteiso-C17 				nov	Q9UIW2	C17 	The typical chemotaxonomic properties of members of the genus Streptomyces were observed for strain CH5-8T, e.g. ll-diaminopimelic acid in cell peptidoglycan, MK-9(H8), MK-9(H6), and MK-9(H4) as major menaquinones and anteiso-C15 : 0, iso-C16 : 0, and anteiso-C17 : 0 as major fatty acids.
32977599	3	81	gly	glycoprotein	397:408	arg1	the glycoprotein	the glycoprotein				Fterm		glycoprotein			Here, two structurally different anti-Ebola 13F6 antibodies, recognizing the heavily glycosylated mucin-like domain (MLD) of the glycoprotein (GP), were expressed in transgenic Nicotiana tabacum plants and designed as inexpensive and effective diagnostic antibodies against Ebola virus disease (EVD).
32977599	3	31	gly	glycosylated	353:364	arg1	the glycoprotein	glycoprotein		domain		Fterm		glycoprotein		domain	Here, two structurally different anti-Ebola 13F6 antibodies, recognizing the heavily glycosylated mucin-like domain (MLD) of the glycoprotein (GP), were expressed in transgenic Nicotiana tabacum plants and designed as inexpensive and effective diagnostic antibodies against Ebola virus disease (EVD).
32977599	3	31	gly	glycosylated	353:364	arg1	MLD	MLD		domain		OGER		MLD	O15121	domain	Here, two structurally different anti-Ebola 13F6 antibodies, recognizing the heavily glycosylated mucin-like domain (MLD) of the glycoprotein (GP), were expressed in transgenic Nicotiana tabacum plants and designed as inexpensive and effective diagnostic antibodies against Ebola virus disease (EVD).
31931062	0	63	gly	fucosylated	122:132	arg1	highly fucosylated N-glycans				highly fucosylated N-glycans						Ricin B-like lectin orthologues from two mushrooms, Hericium erinaceus and Stereum hirsutum, enable recognition of highly fucosylated N-glycans.
34482828	0	71	gly	glycosylation	31:43	arg2	N-linked and O-linked glycosylation sites			N-linked and O-linked glycosylation sites						sites	Roles of N-linked and O-linked glycosylation sites in the activity of equine chorionic gonadotropin in cells expressing rat luteinizing hormone/chorionic gonadotropin receptor and follicle-stimulating hormone receptor.
34552927	1	11	gly	attached	266:273	arg1	core proteins AND Glycosaminoglycans	core proteins			Glycosaminoglycans	Fterm		proteins			Glycosaminoglycans (GAGs) including chondroitin sulfate, dermatan sulfate, heparan sulfate, and keratan sulfate, except for hyaluronan that is a free polysaccharide, are covalently attached to core proteins to form proteoglycans.
31924694	4	97	gly	glycopeptide	961:972	arg2	the glycopeptide level			the glycopeptide level						glycopeptide	A comprehensive investigation of the N-glycosylation sites from the adult stages of N. lugens was conducted, allowing a qualitative and quantitative comparison between sexes at the glycopeptide level.
31924694	4	106	gly	N-glycosylation	817:831	arg2	the N-glycosylation sites			the N-glycosylation sites						sites	A comprehensive investigation of the N-glycosylation sites from the adult stages of N. lugens was conducted, allowing a qualitative and quantitative comparison between sexes at the glycopeptide level.
33127381	8	0	gly	CRS1	1098:1101	arg1	the O-glycans	CRS1			the O-glycans	PUBTATOR		CRS1	7291		Identification of α1,2-fucose on the O-glycans of CRS1 expressed in Paneth cells will pave the way for a mechanistic understanding of α1,2-fucose-dependent symbiosis with intestinal bacteria and elimination of pathogenic bacteria in the intestine.
33652358	5	79	gly	used	870:873	arg2	phytochemical compositions			phytochemical compositions						positions	METHODS Combined with biosynthetic pathway analysis, phytochemical compositions identified by UHPLC-Q-Orbitrap HRMS were used to build substantial phytochemical groups and further discover specific Q-markers.
32841408	3	43	gly	heterogeneity	362:374	arg1	glycan				glycan						Because of the heterogeneity of glycan, the structure of rhuEPO was complex with several isoforms.
35116628	9	36	gly	NRG1	1281:1284	arg1	the fucosylated structures	NRG1			the fucosylated structures	PUBTATOR		NRG1	3084		Both AAL ELISA and protein ELISA assays showed that the fucosylated structures of NRG1 had a remarkable increase in BRAF V600E mutant PTC patients compared with BRAF wild type PTC controls.
35116628	9	39	gly	fucosylated	1255:1265	arg1	the fucosylated structures				the fucosylated structures						Both AAL ELISA and protein ELISA assays showed that the fucosylated structures of NRG1 had a remarkable increase in BRAF V600E mutant PTC patients compared with BRAF wild type PTC controls.
32376684	6	70	gly	modified	974:981	arg1	both residues AND oligomannose N-glycans			both residues	oligomannose N-glycans					residues	Lectin blotting, endoglycosidase H digestion, and MS analysis revealed that both residues are modified with oligomannose N-glycans.
33815695	5	38	gly	protein	951:957	arg1	peptidoglycan	protein			peptidoglycan	Fterm		protein			Furthermore, we detected variability in the amount and composition of protein, nucleic acid and peptidoglycan cargo carried by MVs from each S. aureus strain.
33362841	1	78	gly	glycoproteins	246:258	arg1	extracellular glycoproteins	extracellular glycoproteins				Fterm		glycoproteins			The predominant Fascilin 1 (FAS1)-containing proteins in plants belong to the Fasciclin-Like Arabinogalactan-protein (FLA) family of extracellular glycoproteins.
32223833	6	18	gly	acid	886:889	arg1	the cell-wall peptidoglycan			glutamic acid, glycine	the cell-wall peptidoglycan					glutamic acid, glycine	The novel strain contained meso-diaminopimelic acid and 3-OH-diaminopimelic acid, d-glutamic acid, glycine and d-alanine in the cell-wall peptidoglycan.
32223833	6	29	gly	glycine	892:898	arg1	the cell-wall peptidoglycan			glutamic acid, glycine	the cell-wall peptidoglycan					glutamic acid, glycine	The novel strain contained meso-diaminopimelic acid and 3-OH-diaminopimelic acid, d-glutamic acid, glycine and d-alanine in the cell-wall peptidoglycan.
32223833	6	75	gly	d-alanine	904:912	arg1	the cell-wall peptidoglycan			alanine	the cell-wall peptidoglycan					alanine	The novel strain contained meso-diaminopimelic acid and 3-OH-diaminopimelic acid, d-glutamic acid, glycine and d-alanine in the cell-wall peptidoglycan.
33807914	3	43	gly	glycoprotein	511:522	arg1	the intestinal glycoprotein Mucin2	the intestinal glycoprotein Mucin2				Fterm		glycoprotein			Previous work has shown that fucose, the terminal glycan chain component of the intestinal glycoprotein Mucin2, and fucoidan polysaccharides have an anti-inflammatory effect in some mouse models of colitis.
33807914	3	50	gly	Mucin2	524:529	arg1	the terminal glycan chain component	Mucin2			the terminal glycan chain component	PUBTATOR		Mucin2	Q02817		Previous work has shown that fucose, the terminal glycan chain component of the intestinal glycoprotein Mucin2, and fucoidan polysaccharides have an anti-inflammatory effect in some mouse models of colitis.
33807914	3	50	gly	Mucin2	524:529	arg1	fucose	Mucin2			fucose	PUBTATOR		Mucin2	Q02817		Previous work has shown that fucose, the terminal glycan chain component of the intestinal glycoprotein Mucin2, and fucoidan polysaccharides have an anti-inflammatory effect in some mouse models of colitis.
34163440	7	41	gly	glycoproteins	1141:1153	arg1	The differential glycoproteins	The differential glycoproteins				Fterm		glycoproteins			The differential glycoproteins were mainly involved in various types of N-glycan biosynthesis, mRNA surveillance pathway, and protein processing in the endoplasmic reticulum.
34020817	2	84	gly	glycoprotein	245:256	arg1	The HIV-1 envelope (Env) glycoprotein	The HIV-1 envelope (Env) glycoprotein				Fterm		glycoprotein			The HIV-1 envelope (Env) glycoprotein trimer is covered by N-linked glycan comprising half its mass and requires both trimer assembly and subunit cleavage to fold into a prefusion-closed conformation.
32600019	14	70	gly	C	1798:1798	arg1	carbohydrate	vitamin C			carbohydrate	Cterm		vitamin C			CONCLUSIONS The juice samples contain appreciable amounts of carbohydrate, vitamin C, flavonoids, alkaloids, and glycosides.
33363672	3	88	gly	glycopeptides	540:552	arg2	glycopeptides			glycopeptides						glycopeptides	In recent years, several bioinformatic tools were developed to facilitate and improve both the identification and quantification of glycopeptides.
33363672	0	49	gly	glycopeptide	67:78	arg2	maximized glycopeptide identification			maximized glycopeptide identification						glycopeptide	Semiautomated glycoproteomics data analysis workflow for maximized glycopeptide identification and reliable quantification.
33821278	6	40	gly	glycoprotein	1033:1044	arg1	the wild-type S glycoprotein N-linked glycans				the wild-type S glycoprotein N-linked glycans						Compared with soluble or solubilized S glycoproteins modified to prevent proteolytic cleavage and to retain a prefusion conformation, more of the wild-type S glycoprotein N-linked glycans are processed to complex forms.
33821278	6	70	gly	glycoproteins	914:926	arg1	soluble or solubilized S glycoproteins	soluble or solubilized S glycoproteins				PUBTATOR		S glycoproteins	43740568		Compared with soluble or solubilized S glycoproteins modified to prevent proteolytic cleavage and to retain a prefusion conformation, more of the wild-type S glycoprotein N-linked glycans are processed to complex forms.
33821278	11	29	gly	glycoprotein	1818:1829	arg1	the native SARS-CoV-2 S glycoprotein	the native SARS-CoV-2 S glycoprotein				PUBTATOR		S glycoprotein	43740568		These findings enhance our understanding of the Golgi processing of the native SARS-CoV-2 S glycoprotein carbohydrates and could assist the design of interventions.
33127381	4	44	gly	glycoproteins	587:599	arg1	glycoproteins	glycoproteins				Fterm		glycoproteins			However, glycoproteins in Paneth cells carrying α1,2-fucose have not yet been identified.
32385312	5	47	gly	suberin	1051:1057	arg1	polysaccharides	suberin			polysaccharides	Fterm		suberin			The results show that, in general, drought does not affect the proportion of the main components of cork, the monomers of suberin or of polysaccharides, with few exceptions e.g. drought increased ethanol extractives and xylose in polysaccharides and decreased arabinose in polysaccharides.
33090600	6	41	gly	neoglycopeptide	1229:1243	arg2	the neoglycopeptide			the neoglycopeptide						neoglycopeptide	Finally, a cytokine secretion assay was carried out on human monocyte-derived DCs, which showed the ability of the neoglycopeptide decorated with a single LeX to alter the balance of pro- and anti-inflammatory cytokines, inducing a tolerogenic response.
31924694	7	29	gly	N-glycosylation	1409:1423	arg2	Male- and female-specific N-glycosylation sites			Male- and female-specific N-glycosylation sites						sites	Male- and female-specific N-glycosylation sites were identified, and some of these sex-specific N-glycosylation sites were shown to be derived from proteins with a putative role in insect reproduction.
31924694	7	79	gly	N-glycosylation	1479:1493	arg2	these sex-specific N-glycosylation sites			these sex-specific N-glycosylation sites						sites	Male- and female-specific N-glycosylation sites were identified, and some of these sex-specific N-glycosylation sites were shown to be derived from proteins with a putative role in insect reproduction.
31931062	5	45	gly	glycoprotein	776:787	arg1	N-linked glycoprotein transferrin	N-linked glycoprotein transferrin				Fterm		glycoprotein			The hemagglutination activity of rSHL1 was inhibited by N-linked glycoprotein transferrin.
33363672	8	45	gly	glycopeptide	1304:1315	arg2	glycopeptide quantification			glycopeptide quantification						glycopeptide	For glycopeptide quantification, the performance of LaCyTools was compared to Skyline, and GlycopeptideGraphMS.
32823755	9	2	gly	beet	1794:1797	arg1	FOS	FOS			beet	OGER		FOS	P01100		This study points out the combination of FOS from sugar beet and garlic residues as a potential prebiotic to be used in young ruminants' nutrition in order to improve production yields.
33821278	4	53	gly	glycoproteins	622:634	arg1	spike glycoproteins	spike glycoproteins				PUBTATOR		spike glycoproteins	43740568		We found that virus-like particles produced by coexpression of SARS-CoV-2 S, M, E and N proteins contained spike glycoproteins that were extensively modified by complex carbohydrates.
33821278	4	89	gly	modified	658:665	arg1	spike glycoproteins AND complex carbohydrates	spike glycoproteins			complex carbohydrates	PUBTATOR		spike glycoproteins	43740568		We found that virus-like particles produced by coexpression of SARS-CoV-2 S, M, E and N proteins contained spike glycoproteins that were extensively modified by complex carbohydrates.
33115649	3	39	gly	HOS	419:421	arg1	The sugar composition	HOS			The sugar composition	OGER		HOS	Q5SRY7		The sugar composition of the purified HOS with an weight-average molecular weight of 178.4 ± 2.1 kDa and a polydispersity index of 1.02 ± 0.02 contained galacturonic acid (34%), galactose (31%), rhamnose (21%), arabinose (4.2%), glucuronic acid (2.5%), xylose (1.2%), and other monosaccharides (6.1%) by weight.
34211273	10	3	gly	used	1707:1710	arg2	This potential composite			This potential composite						composite	This potential composite could be used as scaffolds in bone tissue engineering application after in vivo studies.
33301522	6	87	gly	N-glycopeptides	1395:1409	arg2	intact N-glycopeptides			intact N-glycopeptides						N-glycopeptides	Furthermore, the optimized workflow was applied to the analysis of intact N-glycopeptides in two-dimensional (2D) and three-dimensional (3D)-cultured breast cancer cells in vitro and xenografted tumors in mice.
34576834	6	55	gly	fucosylated	1249:1259	arg1	fucosylated glycans				fucosylated glycans						(3) Results: Among the main features discriminant for infants who did not experience any reported bronchitis (n = 80/106) or LRTI (n = 70/103) were the 2-HMO formula containing 2'FL and LNnT, higher acetate, fucosylated glycans and Bifidobacterium, as well as lower succinate, butyrate, propionate and 5-aminovalerate, along with Carnobacteriaceae members and Escherichia.
34482828	12	54	gly	glycosylation	1870:1882	arg2	Asn56			Asn56				chorionic gonadotropin		Asn56	This indicated that the glycosylation site at Asn56 of the α-subunit plays a pivotal role in the LH-like activity of eCG.
34482828	12	54	gly	glycosylation	1870:1882	arg2	the glycosylation site			the glycosylation site						site	This indicated that the glycosylation site at Asn56 of the α-subunit plays a pivotal role in the LH-like activity of eCG.
32862508	7	50	gly	fucosylated	1354:1364	arg1	fucosylated N-glycans				fucosylated N-glycans						Therefore, the results from this study highly suggested that MrNV-VLPs preferentially attach to fucosylated N-glycans in the susceptible gill tissues, and these findings could lead to the development of strategies that target virus-host surface glycan interactions to reduce MrNV infections.
32359163	7	3	gly	glycosylation	1456:1468	arg2	the N-linked and O-linked glycosylation motifs			the N-linked and O-linked glycosylation motifs						motifs	Sequence features of the globular and disordered regions clearly correlate with one another, implying coevolution of these distinct regions, as well as with the N-linked and O-linked glycosylation motifs.
32386244	2	49	gly	used	538:541	arg2	The prepared nanocomposite			The prepared nanocomposite						nanocomposite	The prepared nanocomposite was used to isolate and preconcentrate celecoxib from human breast milk, urine and plasma samples.
32131144	3	10	gly	ALF	532:534	arg1	poly(I:C)/D-GalN	ALF			poly(I:C)/D-GalN	OGER		ALF	Q8R4I4		However, the molecular differences among three ALF models (LPS/D-GalN, poly(I:C)/D-GalN, and CpG DNA/D-GalN), are unclear.
32131144	3	10	gly	ALF	532:534	arg1	LPS/D-GalN	ALF			LPS/D-GalN	OGER		ALF	Q8R4I4		However, the molecular differences among three ALF models (LPS/D-GalN, poly(I:C)/D-GalN, and CpG DNA/D-GalN), are unclear.
32131144	3	10	gly	ALF	532:534	arg1	CpG DNA/D-GalN	ALF			CpG DNA/D-GalN	OGER		ALF	Q8R4I4		However, the molecular differences among three ALF models (LPS/D-GalN, poly(I:C)/D-GalN, and CpG DNA/D-GalN), are unclear.
32376684	8	55	gly	N-glycosylation	1225:1239	arg2	both N-glycosylation sites			both N-glycosylation sites						sites	However, simultaneous substitution of both N-glycosylation sites affected both EOGT maturation and expression levels without an apparent change in enzymatic activity, suggesting that N-glycosylation at a single site is sufficient for EOGT maturation and expression.
32376684	8	33	gly	N-glycosylation	1365:1379	arg1	a single site			site						site	However, simultaneous substitution of both N-glycosylation sites affected both EOGT maturation and expression levels without an apparent change in enzymatic activity, suggesting that N-glycosylation at a single site is sufficient for EOGT maturation and expression.
35126378	0	25	gly	D-Ala-Ended	10:20	arg1	D-Ala-Ended Peptidoglycan Precursors			Ala	D-Ala-Ended Peptidoglycan Precursors					Ala	Effect of D-Ala-Ended Peptidoglycan Precursors on the Immune Regulation of Lactobacillus plantarum Strains.
32220841	8	67	gly	FOS	1167:1169	arg1	the growth and oligosaccharide utilization	FOS			the growth and oligosaccharide utilization	OGER		FOS	P01100		We compared the growth and oligosaccharide utilization of GOS and FOS by bifidobacterial species in pure culture and coculture.
33127381	2	11	gly	α1,2-fucosylated	298:313	arg1	α1,2-fucosylated mucin	α1,2-fucosylated mucin				PUBTATOR		α1,2-fucosylated mucin	100508689		It is postulated that α1,2-fucosylated mucin secreted from goblet cells is involved in defending an organism against infections, but the detailed molecular mechanisms are yet to be elucidated.
33125241	6	36	gly	glycopeptide	1233:1244	arg2	glycopeptide			glycopeptide						glycopeptide	Using high-field asymmetric waveform ion mobility spectrometry (FAIMS) fractionation, we show that at high compensation voltages (CVs), short aliphatic glycopeptides can be enriched from complex samples, providing an alternative means to identify glycopeptide recalcitrant to hydrophilic-based enrichment.
33125241	6	58	gly	glycopeptides	1138:1150	arg2	short aliphatic glycopeptides			short aliphatic glycopeptides						glycopeptides	Using high-field asymmetric waveform ion mobility spectrometry (FAIMS) fractionation, we show that at high compensation voltages (CVs), short aliphatic glycopeptides can be enriched from complex samples, providing an alternative means to identify glycopeptide recalcitrant to hydrophilic-based enrichment.
33127381	7	35	gly	modified	970:977	arg3	unique Thr residues AND O-glycans			unique Thr residues	O-glycans					Thr residues	Unlike other antimicrobial α-defensin proteins, CRS1 contains unique Thr residues, which are modified with O-glycans, with 3HexNAc2Hex1Fuc1NeuAc being the main glycoform.
32376684	0	24	gly	N-Glycans	0:8	arg1	EOGT	EOGT			N-Glycans	PUBTATOR		EOGT	285203		N-Glycans on EGF domain-specific O-GlcNAc transferase (EOGT) facilitate EOGT maturation and peripheral endoplasmic reticulum localization.
33821278	1	10	gly	glycoprotein	172:183	arg1	its spike (S) glycoprotein	its spike (S) glycoprotein				Fterm		glycoprotein			The SARS-CoV-2 coronavirus, the etiologic agent of COVID-19, uses its spike (S) glycoprotein anchored in the viral membrane to enter host cells.
32672838	4	73	gly	glycoprotein	1215:1226	arg1	the glycoprotein	the glycoprotein				Fterm		glycoprotein			The presence of other sugars was not detected by 1 H NMR and HPAEC-PAD, suggesting that HPAs hydrolyze only the terminal glycosidic bond in the glycoprotein, resulting in the selective release of sialic acid from AGP.
33125241	10	30	gly	glycopeptides	1757:1769	arg2	access glycopeptides			access glycopeptides						glycopeptides	Taken together, these results demonstrate that FAIMS provides an alternative means to access glycopeptides and is a valuable tool for glycoproteomic analysis.
33044149	8	23	gly	glycine	1013:1019	arg1	the peptidoglycans			glutamic acid and glycine	the peptidoglycans					glutamic acid and glycine	The strain Q22T contained 2,4-diaminobutyric acid, alanine acid, glutamic acid and glycine in the peptidoglycans.
33044149	8	67	gly	acid	1004:1007	arg1	the peptidoglycans			glutamic acid and glycine	the peptidoglycans					glutamic acid and glycine	The strain Q22T contained 2,4-diaminobutyric acid, alanine acid, glutamic acid and glycine in the peptidoglycans.
32706435	4	28	gly	glycoproteins	580:592	arg1	H. hispanica S-layer glycoproteins	H. hispanica S-layer glycoproteins				Fterm		glycoproteins			Our previous work showed that H. hispanica S-layer glycoproteins are modified by an N-linked glucose-α-(1, 2)-[sulfoquinovosamine-β-(1, 6)-]galactose trisaccharide and an O-linked glucose-α-(1, 4)-galactose disaccharide.
33362841	8	2	gly	glycosylation	1419:1431	arg1	cell wall glycoproteins	cell wall glycoproteins				Fterm		glycoproteins			A FLA16-YFP fusion protein driven by the endogenous putative FLA16 promoter in wild type background showed expression in cells with secondary cell walls, and FLA16 displayed characteristics of cell wall glycoproteins with moderate glycosylation.
33362841	8	4	gly	glycoproteins	1391:1403	arg1	cell wall glycoproteins	cell wall glycoproteins				Fterm		glycoproteins			A FLA16-YFP fusion protein driven by the endogenous putative FLA16 promoter in wild type background showed expression in cells with secondary cell walls, and FLA16 displayed characteristics of cell wall glycoproteins with moderate glycosylation.
33038510	7	110	gly	glycoform	1313:1321	arg1	MFAP4 glycoform	MFAP4 glycoform				PUBTATOR		MFAP4	4239		The specificity of MFAP4 glycoform containing sLex in PDA tissues shows its relevance as a potential PDA biomarker.
32908918	5	75	gly	peptide	699:705	arg1	The glucagon-like peptide 2 (GLP-2) and lipopolysaccharide (LPS) levels				The glucagon-like peptide 2 (GLP-2) and lipopolysaccharide (LPS) levels						The glucagon-like peptide 2 (GLP-2) and lipopolysaccharide (LPS) levels in plasma and intestinal tissues were measured by ELISA and Limulus test, respectively.
32310329	4	13	gly	FV	557:558	arg1	The glycan profile	FV			The glycan profile	Cterm		FV	2153		The glycan profile of FV, as well as how it affects the activity, stability, and immunogenicity, remains unknown.
33038510	13	95	gly	glycoform	2403:2411	arg1	its sLex glycoform				its sLex glycoform						MFAP4 is found in the extracellular matrix in PDA and although its role in cancer progression is unclear, its sLex glycoform could be a potential biomarker in pancreatic ductal adenocarcinoma.
35126378	8	47	gly	D-Ala-ended	1383:1393	arg1	D-Ala-ended peptidoglycan precursors			Ala	D-Ala-ended peptidoglycan precursors					Ala	These results indicate that D-Ala-ended peptidoglycan precursors play a central role in the variable immunomodulatory ability of L. plantarum.
32053092	8	82	gly	acids	1449:1453	arg1	d-alanine			d-alanine						alanine	The peptidoglycan type was supposed to be the B2ß with amino acids d-alanine, d-glutamic acid, glycine, l-homoserine and d-ornithine.
32053092	8	82	gly	acids	1449:1453	arg1	glycine			glutamic acid, glycine						glutamic acid, glycine	The peptidoglycan type was supposed to be the B2ß with amino acids d-alanine, d-glutamic acid, glycine, l-homoserine and d-ornithine.
32518945	2	39	gly	glycoproteins	343:355	arg1	heparin	heparin				Fterm		heparin			A subset of these are adept at scavenging host glycans within this environment, including mucin O-linked glycans, N-linked glycoproteins and highly sulfated glycosaminoglycans (GAGs) such as heparin (Hep) and chondroitin sulfate (CS).
32518945	2	39	gly	glycoproteins	343:355	arg1	N-linked glycoproteins	N-linked glycoproteins				Fterm		glycoproteins			A subset of these are adept at scavenging host glycans within this environment, including mucin O-linked glycans, N-linked glycoproteins and highly sulfated glycosaminoglycans (GAGs) such as heparin (Hep) and chondroitin sulfate (CS).
34482828	1	10	gly	glycoprotein	354:365	arg1	the glycoprotein hormone family	the glycoprotein hormone family				Fterm		glycoprotein			BACKGROUND Equine chorionic gonadotropin (eCG), which comprises highly glycosylated α-subunit and β-subunit, is a unique member of the glycoprotein hormone family as it elicits both follicle-stimulating hormone (FSH)-like and luteinizing hormone (LH)-like responses in non-equid species.
34482828	1	127	gly	glycosylated	290:301	arg1	highly glycosylated α-subunit	highly glycosylated α-subunit				Fterm		α-subunit			BACKGROUND Equine chorionic gonadotropin (eCG), which comprises highly glycosylated α-subunit and β-subunit, is a unique member of the glycoprotein hormone family as it elicits both follicle-stimulating hormone (FSH)-like and luteinizing hormone (LH)-like responses in non-equid species.
32459612	7	26	gly	attached	1505:1512	arg1	N-linked membrane glycoproteins AND terminal sialic acids	N-linked membrane glycoproteins			terminal sialic acids	Fterm		glycoproteins			We can conclude that terminal sialic acids attached to N-linked membrane glycoproteins on B cells are used for virus attachment and are essential for successful virus infection.
32459612	7	37	gly	glycoproteins	1535:1547	arg1	N-linked membrane glycoproteins	N-linked membrane glycoproteins				Fterm		glycoproteins			We can conclude that terminal sialic acids attached to N-linked membrane glycoproteins on B cells are used for virus attachment and are essential for successful virus infection.
33127381	0	56	gly	O-glycosylated	66:79	arg1	O-glycosylated protein	O-glycosylated protein				Fterm		protein			Glycoproteomic analysis identifies cryptdin-related sequence 1 as O-glycosylated protein modified with α1,2-fucose in the small intestine.
31730034	5	13	gly	K3-2T	515:519	arg1	The cell-wall peptidoglycan	K3-2T			The cell-wall peptidoglycan	Cterm		K3-2T			The cell-wall peptidoglycan of strain K3-2T contained lysine (the diagnostic diamino acid), glutamic acid, alanine, ornithine, glycine and serine.
34123172	6	37	gly	glycosylation	1086:1098	arg2	their glycosylation sites			their glycosylation sites						sites	Our results suggest that glycoforms displaying highly correlated motion in their glycosylation sites tend to bind cellulose with high affinity and lignin with low affinity.
32376684	10	11	gly	N-glycosylation	1710:1724	arg1	EOGT	EOGT				PUBTATOR		EOGT	285203		Moreover, the N263Q/N354Q variant exhibited altered subcellular distribution within the ER in HEK293T cells, indicating that N-glycosylation of EOGT is required for its ER localization at the cell periphery.
32127446	8	87	gly	glycoproteins	1725:1737	arg1	mucin glycoproteins	mucin glycoproteins				Fterm		glycoproteins			Pathogens such as P. aeruginosa that lack sialidases may rely on enzymes from other bacteria to utilize mucin-derived monosaccharides.IMPORTANCE One of the first lines of defense present at mucosal epithelial tissues is mucus, which is a highly viscous material formed by mucin glycoproteins.
33125241	8	46	gly	glycopeptides	1499:1511	arg2	glycopeptides			glycopeptides						glycopeptides	Excitingly, the ability to enrich glycopeptides using FAIMS appears generally applicable, with the N-linked glycopeptides of Campylobacter fetus subsp.
33125241	8	49	gly	glycopeptides	1573:1585	arg2	the N-linked glycopeptides			the N-linked glycopeptides						glycopeptides	Excitingly, the ability to enrich glycopeptides using FAIMS appears generally applicable, with the N-linked glycopeptides of Campylobacter fetus subsp.
32298636	1	31	gly	sialylated	230:239	arg1	sialylated glycans				sialylated glycans						Host lipid composition influences many stages of the influenza A virus (IAV) entry process, including initial binding of IAV to sialylated glycans, fusion between the viral envelope and the host membrane, and the formation of a fusion pore through which the viral genome is transferred into a target cell.
35116628	1	0	gly	glycoprotein	149:160	arg1	a membrane glycoprotein	a membrane glycoprotein				Fterm		glycoprotein			BACKGROUND Neuregulin 1 (NRG1) is a membrane glycoprotein mediating cell-to-cell signaling and has a crucial role in the growth and development of various organ systems.
35116628	1	0	gly	glycoprotein	149:160	arg1	BACKGROUND Neuregulin 1	BACKGROUND Neuregulin 1				PUBTATOR		Neuregulin 1	3084		BACKGROUND Neuregulin 1 (NRG1) is a membrane glycoprotein mediating cell-to-cell signaling and has a crucial role in the growth and development of various organ systems.
33295623	2	59	gly	glycoprotein	432:443	arg1	the glycoprotein	the glycoprotein				Fterm		glycoprotein			Both such modifications can coexist in this domain of the glycoprotein.
35141446	1	86	gly	glycoprotein	284:295	arg1	a specific glycoprotein	a specific glycoprotein				Fterm		glycoprotein			Equine chorionic gonadotropin (eCG), produced by the endometrial cups of the placenta after the first trimester, is a specific glycoprotein that displays dual luteinizing hormone (LH)-like and follicle-stimulating hormone (FSH)-like effects in non-equid species.
35141446	1	86	gly	glycoprotein	284:295	arg1	Equine chorionic gonadotropin	Equine chorionic gonadotropin				OGER		chorionic gonadotropin			Equine chorionic gonadotropin (eCG), produced by the endometrial cups of the placenta after the first trimester, is a specific glycoprotein that displays dual luteinizing hormone (LH)-like and follicle-stimulating hormone (FSH)-like effects in non-equid species.
31931062	8	5	gly	fucosylated	1269:1279	arg1	highly fucosylated N-glycans				highly fucosylated N-glycans						Finally, rSHL1 and rHEL1 were comparable in their ability to detect highly fucosylated N-glycans within glycoproteins on the surface of SW1116 human colorectal carcinoma cells.
31931062	8	69	gly	glycoproteins	1298:1310	arg1	glycoproteins				glycoproteins						Finally, rSHL1 and rHEL1 were comparable in their ability to detect highly fucosylated N-glycans within glycoproteins on the surface of SW1116 human colorectal carcinoma cells.
33149259	5	62	gly	glycoforms	840:849	arg1	α2,3-SA glycoforms	α2,3-SA glycoforms				PUBTATOR		2	170589		PSA was immunoprecipitated and α2,6-SA were separated from α2,3-SA glycoforms using SNA affinity chromatography.
33620525	7	52	gly	DCY120T	1100:1106	arg1	peptidoglycan	DCY120T			peptidoglycan	Cterm		DCY120T			The amino acids in peptidoglycan of strain DCY120T were lysine, alanine, glutamic acid, and aspartic acid.
34712749	6	66	gly	glycopeptides	1200:1212	arg2	Concanavalin A enriched glycopeptides			Concanavalin A enriched glycopeptides						glycopeptides	The first one refers to the deglycoproteomics dataset, which covers nanoLC-MS/MS analysis of Concanavalin A enriched glycopeptides released by endoglycosidase digestion from A375 melanoma cell lysates.
33363672	6	84	gly	glycopeptide	1017:1028	arg2	Initial glycopeptide identification			Initial glycopeptide identification						glycopeptide	Initial glycopeptide identification based on MS/MS data was aided by the Byonic software.
31242281	1	49	gly	glycoproteins	155:167	arg1	hydroxyproline-rich glycoproteins	hydroxyproline-rich glycoproteins				Fterm		glycoproteins			BACKGROUND AND AIMS Extensins are hydroxyproline-rich glycoproteins thought to strengthen the plant cell wall, one of the first barriers against pathogens, through intra- and intermolecular cross-links.
31242281	2	14	gly	glycoprotein	400:411	arg1	the glycoprotein	the glycoprotein				Fterm		glycoprotein			The glycan moiety of extensins is believed to confer the correct structural conformation to the glycoprotein, leading to self-assembly within the cell wall that helps limit microbial adherence and invasion.
33404253	4	7	gly	N-glycosylation	844:858	arg2	N-glycosylation sites			N-glycosylation sites						sites	Electrophoresis showed that B. alcatraz venom differs from B. jararaca and B. insularis; however, N-glycan removal revealed similarities between them, indicating that the occupation of N-glycosylation sites contributes to interspecies variability in the B. jararaca complex.
31924694	5	28	gly	N-glycosylation	1216:1230	arg2	over 1300 N-glycosylation sites			over 1300 N-glycosylation sites						sites	N-glycopeptide enrichment via lectin capturing using the high mannose/paucimannose-binding lectin Concanavalin A, or the Rhizoctonia solani agglutinin which interacts with complex N-glycans, resulted in the identification of over 1300 N-glycosylation sites derived from over 600 glycoproteins.
31924694	5	33	gly	N-glycopeptide	981:994	arg2	N-glycopeptide			N-glycopeptide						N-glycopeptide	N-glycopeptide enrichment via lectin capturing using the high mannose/paucimannose-binding lectin Concanavalin A, or the Rhizoctonia solani agglutinin which interacts with complex N-glycans, resulted in the identification of over 1300 N-glycosylation sites derived from over 600 glycoproteins.
31924694	5	37	gly	glycoproteins	1260:1272	arg1	over 600 glycoproteins	over 600 glycoproteins				Fterm		glycoproteins			N-glycopeptide enrichment via lectin capturing using the high mannose/paucimannose-binding lectin Concanavalin A, or the Rhizoctonia solani agglutinin which interacts with complex N-glycans, resulted in the identification of over 1300 N-glycosylation sites derived from over 600 glycoproteins.
32359163	8	35	gly	glycosylation	1589:1601	arg2	glycosylation motifs			glycosylation motifs						motifs	We reconstruct the overall evolutionary history of the FLAs, annotated with the changing domain architectures, glycosylation motifs, number and length of AG regions, and disordered region sequence features.
35573890	9	31	gly	CIs	1283:1285	arg1	glycan variants	CIs			glycan variants	OGER		CIs	Q9NSE2		Finally, an in-depth analysis of glycan variants of CIs was performed through the detection of enriched glycopeptides.
35573890	9	52	gly	glycopeptides	1335:1347	arg2	enriched glycopeptides			enriched glycopeptides						glycopeptides	Finally, an in-depth analysis of glycan variants of CIs was performed through the detection of enriched glycopeptides.
33539901	2	11	gly	site	579:582	arg1	a C-terminal peptide			a C-terminal peptide						peptide	In this study, recombinant single-chain Japanese eel Gths (rGth: rFsh and rLh), and recombinant chimeric Gths (rGth-hCTPs: rFsh-hCTP and rLh-hCTP; rGth-eCTPs: rFsh-eCTP and rLh-eCTP) with an extra O-glycosylation site (either a C-terminal peptide of human (hCTP) or equine (eCTP) chorionic gonadotropin), which are known to prolong the half-life of glycoprotein were produced in HEK293 cells and highly purified.
33539901	2	62	gly	O-glycosylation	563:577	arg2	an extra O-glycosylation site			an extra O-glycosylation site						site	In this study, recombinant single-chain Japanese eel Gths (rGth: rFsh and rLh), and recombinant chimeric Gths (rGth-hCTPs: rFsh-hCTP and rLh-hCTP; rGth-eCTPs: rFsh-eCTP and rLh-eCTP) with an extra O-glycosylation site (either a C-terminal peptide of human (hCTP) or equine (eCTP) chorionic gonadotropin), which are known to prolong the half-life of glycoprotein were produced in HEK293 cells and highly purified.
33539901	2	96	gly	glycoprotein	715:726	arg1	glycoprotein	glycoprotein				Fterm		glycoprotein			In this study, recombinant single-chain Japanese eel Gths (rGth: rFsh and rLh), and recombinant chimeric Gths (rGth-hCTPs: rFsh-hCTP and rLh-hCTP; rGth-eCTPs: rFsh-eCTP and rLh-eCTP) with an extra O-glycosylation site (either a C-terminal peptide of human (hCTP) or equine (eCTP) chorionic gonadotropin), which are known to prolong the half-life of glycoprotein were produced in HEK293 cells and highly purified.
35116628	2	92	gly	NRG1	447:450	arg1	multiple glycan patterns	NRG1			multiple glycan patterns	PUBTATOR		NRG1	3084		Our study explored its diagnostic value in distinguishing BRAF V600E mutant status in papillary thyroid cancer (PTC) patients by analyzing multiple glycan patterns of serum NRG1 through lectin assays.
31746729	8	48	gly	C16 	1222:1225	arg1	iso-C16 			iso-C16 				nov	Q9UIW2	C16 	The major fatty acids (>5 %) of strain SYSU K30003T were anteiso-C15:0, C16 : 0, anteiso-C17 : 0 and iso-C16 : 0, while those of strain SYSU K30004T were anteiso-C15:0, C16:0, anteiso-C17 : 0, iso-C15 : 0, iso-C16:0 and iso-C17 : 0.
33821278	7	60	gly	modified	1230:1237	arg3	Asn 234 AND processed glycans	S trimers		Asn 234	processed glycans			S trimers	43740568	Asn 234	Even Asn 234, a significant percentage of which is decorated by high-mannose glycans on soluble and virion S trimers, is predominantly modified in the Golgi by processed glycans.
33821278	7	78	gly	glycans	1172:1178	arg1	soluble and virion S trimers	S trimers			glycans	PUBTATOR		S trimers	43740568		Even Asn 234, a significant percentage of which is decorated by high-mannose glycans on soluble and virion S trimers, is predominantly modified in the Golgi by processed glycans.
32127446	2	101	gly	glycosylated	319:330	arg1	heavily glycosylated proteins	heavily glycosylated proteins				Fterm		proteins			The major structural components of mucus are heavily glycosylated proteins called mucins.
33295623	1	60	gly	threonine	248:256	arg1	α-O-GalNAc			threonine residues	α-O-GalNAc					threonine residues	We have carried out a comparative study of the conformational impact of modifications to threonine residues of either α-O-Man or α-O-GalNAc in the context of a sequence from the mucin-like region of α-dystroglycan.
33295623	1	60	gly	threonine	248:256	arg1	α-O-Man			threonine residues	α-O-Man					threonine residues	We have carried out a comparative study of the conformational impact of modifications to threonine residues of either α-O-Man or α-O-GalNAc in the context of a sequence from the mucin-like region of α-dystroglycan.
33125241	5	61	gly	glycopeptides	873:885	arg2	short aliphatic O-linked glycopeptides			short aliphatic O-linked glycopeptides						glycopeptides	Using three Burkholderia species (Burkholderia cenocepacia, Burkholderia Dolosa, and Burkholderia ubonensis), we demonstrate that short aliphatic O-linked glycopeptides are typically absent from HILIC enrichments, yet are readily identified in whole proteome samples.
31924694	9	75	gly	N-glycosylation	1857:1871	arg1	proteins	proteins				Fterm		proteins			Both lectin blotting experiments as well as transcript expression analyses with complete insects and insect tissues confirmed the observed differences in N-glycosylation of proteins between sexes.
32359993	1	12	gly	glycoprotein	132:143	arg1	a cell-surface glycoprotein	a cell-surface glycoprotein				Fterm		glycoprotein			The CD44 gene encodes a cell-surface glycoprotein that participates in a variety of biological processes such as cell interactions, adhesion, hematopoiesis, and tumor metastasis.
33821278	2	9	gly	glycoprotein	243:254	arg1	The S glycoprotein	The S glycoprotein				Cterm		S glycoprotein	43740568		The S glycoprotein is the major target for neutralizing antibodies elicited by natural infection and by vaccines.
32310329	8	52	gly	glycosylation	1257:1269	arg1	proteins	proteins				Fterm		proteins			In addition, the established methodology can be readily applied to analyze glycosylation patterns of proteins with more than 2000 amino acids.
33301522	2	45	gly	N-glycopeptides	437:451	arg2	intact N-glycopeptides			intact N-glycopeptides						N-glycopeptides	The sample pre-processing method used for the analysis of intact N-glycopeptides usually depends on the enrichment of low abundance N-glycopeptides from a tryptic peptide mixture using hydrophilic substances before LC-MS/MS detection.
33301522	2	62	gly	N-glycopeptides	504:518	arg2	low abundance N-glycopeptides			low abundance N-glycopeptides						N-glycopeptides	The sample pre-processing method used for the analysis of intact N-glycopeptides usually depends on the enrichment of low abundance N-glycopeptides from a tryptic peptide mixture using hydrophilic substances before LC-MS/MS detection.
33090600	2	1	gly	N-glycosylation	311:325	arg1	Asn31	MOG		Asn31				MOG	Q16653	Asn31	Post-translational N-glycosylation of Asn31 of MOG seems to play a key role in modulating the immune response towards myelin.
32823755	5	0	gly	residues	965:972	arg1	fructooligosaccharides			residues	fructooligosaccharides					residues	We investigated the effect of milk supplementation with a combination of two well-known prebiotics, fructooligosaccharides (FOS) from sugar beet and garlic residues (all together named as "additive"), exerted on preweaned lamb growth and the composition of their fecal microbiota, by using 16S rRNA gene amplicon high-throughput sequencing.
32823755	5	45	gly	beet	949:952	arg1	FOS	FOS			beet	OGER		FOS	P01100		We investigated the effect of milk supplementation with a combination of two well-known prebiotics, fructooligosaccharides (FOS) from sugar beet and garlic residues (all together named as "additive"), exerted on preweaned lamb growth and the composition of their fecal microbiota, by using 16S rRNA gene amplicon high-throughput sequencing.
33726981	1	3	gly	glycoproteins	166:178	arg1	glycoproteins	glycoproteins				Fterm		glycoproteins			Changes in glycan levels could directly affect the biochemical properties of glycoproteins and thus influence their physiological functions.
34482828	16	70	gly	glycosylation	2330:2342	arg2	the N-linked glycosylation site			the N-linked glycosylation site						site	The findings of this study suggest that the LH-like and FSH-like activities of eCG are regulated by the N-linked glycosylation site at Asn56 of the eCG α-subunit and/or by the O-linked glycosylation sites of the eCG β-subunit.
34482828	16	87	gly	glycosylation	2402:2414	arg2	the O-linked glycosylation sites	β-subunit		sites		Fterm		β-subunit		sites	The findings of this study suggest that the LH-like and FSH-like activities of eCG are regulated by the N-linked glycosylation site at Asn56 of the eCG α-subunit and/or by the O-linked glycosylation sites of the eCG β-subunit.
33038510	2	9	gly	glycoproteins	493:505	arg1	glycoproteins	glycoproteins				Fterm		glycoproteins			Since PDA shows an altered glycan expression, here we have focused on finding novel potential biomarkers, namely glycoproteins that express the tumor associated carbohydrate structure sialyl-Lewis x (sLex), which is described in PDA.
32531254	5	22	gly	glycosylation	1179:1191	arg2	the O-linked glycosylation site			the O-linked glycosylation site						site	This implicated glycosylation as a factor in antibody recognition and synthetic peptides spanning the two N-linked and one O-linked glycosylation regions showed that SHBG recognition by monoclonal antibody 7H9 could be disrupted by a peptide spanning the O-linked glycosylation site.
32310329	6	60	gly	N-glycopeptides	953:967	arg2	57 unique N-glycopeptides			57 unique N-glycopeptides						N-glycopeptides	RESULTS/CONCLUSION A total of 57 unique N-glycopeptides and 51 O-glycopeptides were identified, which were categorized into 40 N-glycan and 17 O-glycan compositions.
32310329	6	61	gly	O-glycopeptides	976:990	arg2	51 O-glycopeptides			51 O-glycopeptides						O-glycopeptides	RESULTS/CONCLUSION A total of 57 unique N-glycopeptides and 51 O-glycopeptides were identified, which were categorized into 40 N-glycan and 17 O-glycan compositions.
32752259	5	1	gly	glycoproteins	833:845	arg1	most CRC glycoproteins	most CRC glycoproteins				Fterm		glycoproteins			However, we failed to detect the presence of O-linked Tn and STn glycans on most CRC glycoproteins recognized by MGL.
32752259	5	60	gly	presence	781:788	arg2	most CRC glycoproteins AND STn glycans	most CRC glycoproteins			STn glycans	Fterm		glycoproteins			However, we failed to detect the presence of O-linked Tn and STn glycans on most CRC glycoproteins recognized by MGL.
33627655	8	11	gly	sialylated	1251:1260	arg1	sialylated glycans				sialylated glycans						This work highlights a critical role for sialylated glycans in controlling immune suppression and provides new potential targets for cancer immunotherapy in PDAC.
34163440	6	51	gly	N-glycoproteins	1037:1051	arg1	differentially expressed N-glycoproteins	differentially expressed N-glycoproteins				Fterm		N-glycoproteins			For the N-glycoproteome, the numbers of differentially expressed N-glycoproteins were 160, 176, and 128 in T50/T30, T55/T30, and T55/T50, respectively.
32376684	5	83	gly	modified	855:862	arg3	Asn-493 AND N-glycans			Asn-493	N-glycans			EOGT	285203	Asn-493	Within these sites, we found that Asn-263 and Asn-354, but not Asn-493, are modified with N-glycans.
32376684	5	83	gly	modified	855:862	arg3	Asn-354 AND N-glycans			Asn-263 and Asn-354	N-glycans			EOGT	285203	Asn-263 and Asn-354	Within these sites, we found that Asn-263 and Asn-354, but not Asn-493, are modified with N-glycans.
33363672	7	43	gly	glycopeptides	1285:1297	arg2	confidently annotated glycopeptides			confidently annotated glycopeptides						glycopeptides	Additional MS1-based glycopeptide identification relying on accurate mass and retention time differences using GlycopeptideGraphMS considerably expanded the set of confidently annotated glycopeptides.
33363672	7	90	gly	glycopeptide	1120:1131	arg2	Additional MS1-based glycopeptide identification relying			Additional MS1-based glycopeptide identification relying						glycopeptide	Additional MS1-based glycopeptide identification relying on accurate mass and retention time differences using GlycopeptideGraphMS considerably expanded the set of confidently annotated glycopeptides.
